@prefix rdf: . @prefix dbr: . @prefix dbo: . dbr:Ebola rdf:type dbo:Disease . @prefix wikidata: . dbr:Ebola rdf:type wikidata:Q12136 . @prefix owl: . dbr:Ebola rdf:type owl:Thing . @prefix rdfs: . dbr:Ebola rdfs:label "Gor\u0105czka krwotoczna Ebola"@pl , "\u30A8\u30DC\u30E9\u51FA\u8840\u71B1"@ja , "\u0391\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1 \u03B9\u03BF\u03CD \u0388\u03BC\u03C0\u03BF\u03BB\u03B1"@el , "Ebola"@nl , "Penyakit virus Ebola"@in , "Maladie \u00E0 virus Ebola"@fr , "\u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627"@ar , "Ebolafieber"@de , "Ebola"@en , "\u0413\u0435\u043C\u043E\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043B\u0438\u0445\u043E\u0440\u0430\u0434\u043A\u0430 \u042D\u0431\u043E\u043B\u0430"@ru , "Febre hemorr\u00E0gica de l'Ebola"@ca , "\u57C3\u535A\u62C9\u51FA\u8840\u70ED"@zh , "Ebola malsano"@eo , "\u0425\u0432\u043E\u0440\u043E\u0431\u0430, \u044F\u043A\u0443 \u0441\u043F\u0440\u0438\u0447\u0438\u043D\u044E\u0454 \u0432\u0456\u0440\u0443\u0441 \u0415\u0431\u043E\u043B\u0430"@uk , "Malattia da virus Ebola"@it , "Ebola"@cs , "Ebola"@sv , "Enfermedad por el virus del \u00C9bola"@es , "\uC5D0\uBCFC\uB77C \uCD9C\uD608\uC5F4"@ko , "Ebola gaixotasun biriko"@eu , "Doen\u00E7a por v\u00EDrus \u00C9bola"@pt ; rdfs:comment "La enfermedad por el virus del \u00C9bola (EVE), enfermedad del \u00E9bolavirus, fiebre hemorr\u00E1gica del \u00C9bola (FHE), enfermedad del \u00C9bola\u200B o, simplemente, como \u00E9bola,\u200B es una enfermedad causada en el ser humano por el virus del \u00C9bola. Normalmente los s\u00EDntomas comienzan entre los dos d\u00EDas y las tres semanas despu\u00E9s de haber contra\u00EDdo el virus, con fiebre, dolor de garganta, dolores musculares, y dolor de cabeza. Por lo general, siguen n\u00E1useas, v\u00F3mitos y diarrea, junto con fallo hep\u00E1tico y renal. En ese momento, algunos pacientes empiezan a sufrir complicaciones hemorr\u00E1gicas.\u200B"@es , "\u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola Virus Disease \u0627\u062E\u062A\u0635\u0627\u0631\u0627\u064B EVD)\u200F \u0623\u064A\u0636\u0627 \u0627\u0644\u062D\u0645\u0649 \u0627\u0644\u0646\u0632\u0641\u064A\u0629 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola Hemorrhagic Fever \u0627\u062E\u062A\u0635\u0627\u0631\u0627\u064B EHF)\u200F\u060C \u0623\u0648 \u0628\u0628\u0633\u0627\u0637\u0629 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola)\u200F\u060C \u0647\u0648 \u0645\u0631\u0636 \u064A\u0635\u064A\u0628 \u0627\u0644\u0628\u0634\u0631 \u0648\u063A\u064A\u0631\u0647\u0627 \u0645\u0646 \u0627\u0644\u0631\u0626\u064A\u0633\u064A\u0627\u062A \u0627\u0644\u0646\u0627\u062C\u0645\u0629 \u0639\u0646 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627 es. \u0627\u0644\u0639\u0644\u0627\u0645\u0627\u062A \u0648\u0627\u0644\u0623\u0639\u0631\u0627\u0636 \u062A\u0628\u062F\u0623 \u0639\u0627\u062F\u0629 \u0628\u064A\u0646 \u064A\u0648\u0645\u064A\u0646 \u0648\u062B\u0644\u0627\u062B\u0629 \u0623\u0633\u0627\u0628\u064A\u0639 \u0628\u0639\u062F \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0645\u0639 \u0627\u0644\u062D\u0645\u0649\u060C \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u062D\u0644\u0642\u060C \u0622\u0644\u0627\u0645 \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A\u060C \u0648\u0627\u0644\u0635\u062F\u0627\u0639. \u062B\u0645\u060C \u0642\u064A\u0621\u060C \u0625\u0633\u0647\u0627\u0644 \u0648\u0637\u0641\u062D \u0639\u0627\u062F\u0629 \u0645\u0627 \u062A\u062D\u062F\u062B\u060C \u062C\u0646\u0628\u0627 \u0625\u0644\u0649 \u062C\u0646\u0628 \u0645\u0639 \u0627\u0646\u062E\u0641\u0627\u0636 \u0648\u0638\u0627\u0626\u0641 \u0643\u0644\u0627 \u0645\u0646 \u0627\u0644\u0643\u0628\u062F \u0648\u0627\u0644\u0643\u0644\u0649. \u0641\u064A \u0647\u0630\u0627 \u0627\u0644\u0648\u0642\u062A \u064A\u0628\u062F\u0623 \u0628\u0639\u0636 \u0627\u0644\u0646\u0627\u0633 \u0628\u0627\u0644\u0646\u0632\u0641 \u062F\u0627\u062E\u0644\u064A\u0627 \u0648\u062E\u0627\u0631\u062C\u064A\u0627. \u0627\u0644\u0645\u0631\u0636 \u0630\u0648 \u0645\u062E\u0627\u0637\u0631 \u0639\u0627\u0644\u064A\u0629 \u0645\u0646 \u0627\u0644\u0645\u0648\u062A\u060C \u0645\u0645\u0627 \u0623\u0633\u0641\u0631 \u0639\u0646 \u0645\u0642\u062A\u0644 \u0645\u0627 \u0628\u064A\u0646 25 \u064890 \u0641\u064A \u0627\u0644\u0645\u0626\u0629 \u0645\u0646 \u0627\u0644\u0645\u0635\u0627\u0628\u064A\u0646 \u0641\u064A \u0627\u0644\u0645\u062A\u0648\u0633\u0637 \u0646\u062D\u0648 50 \u0641\u064A \u0627\u0644\u0645\u0626\u0629. \u0647\u0630\u0627 \u063A\u0627\u0644\u0628\u0627 \u0645\u0627 \u064A\u0631\u062C\u0639 \u0625\u0644\u0649 \u0627\u0646\u062E\u0641\u0627\u0636 \u0636\u063A\u0637 \u0627\u0644\u062F\u0645 \u0645\u0646 \u0641\u0642\u062F\u0627\u0646 \u0627\u0644\u0633\u0648\u0627\u0626\u0644\u060C \u0648\u0639\u0627\u062F\u0629 \u0645\u0627 \u064A\u0644\u064A \u0628\u0639\u062F 6-16 \u0623\u064A\u0627\u0645 \u0645\u0646 \u0638\u0647\u0648\u0631 \u0627\u0644\u0623\u0639\u0631\u0627\u0636."@ar , "Ebola of ebola hemorragische koorts is een bij mensen voorkomende virusziekte die wordt veroorzaakt door het ebolavirus. De ziekte is zeldzaam en komt voor in de vorm van regionale uitbraken in landen in Midden-Afrika. De naam ebola komt van de gelijknamige rivier in Congo-Kinshasa (destijds Za\u00EFre) waar in 1976 een tweede uitbraak plaatsvond en ebola voor het eerst door Guido van der Groen en Peter Piot werd herkend en aangetoond in de plaats Yambuku, gelegen op 95 kilometer van de rivier de Ebola. De aandoening veroorzaakt een hoog sterftecijfer en er is nog geen specifieke behandeling of geneesmiddel beschikbaar tegen het virus."@nl , "Ebolafieber, nach ICD-10 Ebola-Viruskrankheit, ist eine Infektionskrankheit, die durch Viren der Gattung Ebolavirus hervorgerufen wird. Die Bezeichnung geht auf den Fluss Ebola in der Demokratischen Republik Kongo zur\u00FCck, in dessen N\u00E4he diese Viren 1976 den ersten allgemein bekannten gro\u00DFen Ausbruch verursacht hatten. Von 2014 bis 2016 gab es die weltweit bislang schwerste Ebolafieber-Epidemie in Westafrika."@de , "La malaltia del virus Ebola (tamb\u00E9 febre hemorr\u00E0gica de l'Ebola, EVD o EHF, segons les inicials en angl\u00E8s), o simplement Ebola, \u00E9s una malaltia dels \u00E9ssers humans i altres primats causada per ebolavirus. Els signes i s\u00EDmptomes solen comen\u00E7ar entre dos dies i tres setmanes despr\u00E9s de contraure el virus com a febre, mal de coll, dolors musculars, i mal de cap. Llavors apareixen v\u00F2mits, diarrea i erupci\u00F3 que generalment segueixen, juntament amb la disminuci\u00F3 de la funci\u00F3 del fetge i els ronyons. En aquest moment algunes persones comencen a sagnar tant interna com externament. La malaltia t\u00E9 un alt risc de mort, matant a entre 25 per cent i el 90 per cent dels infectats amb el virus, amb una mitjana cap a 50 per cent. La mort es dona sovint a causa de la baixa pressi\u00F3 sangu\u00EDnia per la p\u00E8rdua d"@ca , "\u4F0A\u6CE2\u62C9\u51FA\u8840\u71B1\uFF08\u53C8\u540D\uFF1A\u4F0A\u6CE2\u62C9\u75C5\u6BD2\u75C5\uFF1B\u901A\u7A31\uFF1A\u4F0A\u6CE2\u62C9\uFF1B\u82F1\u8BED\uFF1AEbola Hemorrhagic Fever\uFF09\u662F\u4E00\u7A2E\u7531\u4F0A\u6CE2\u62C9\u75C5\u6BD2\u5F15\u8D77\uFF0C\u591A\u51FA\u73FE\u65BC\u9748\u9577\u52D5\u7269\u8EAB\u4E0A\u7684\u4EBA\u755C\u5171\u60A3\u50B3\u67D3\u75C5\uFF0C\u56E0\u5728\u57C3\u535A\u62C9\u6CB3\u9644\u8FD1\u53D1\u73B0\uFF0C\u56E0\u6B64\u5F97\u540D\u3002\u7F79\u60A3\u6B64\u75C5\u7684\u4EBA\u6703\u57282\u5929\u81F33\u9031\u5167\u9678\u7E8C\u51FA\u73FE\u767C\u71D2\u3001\u982D\u75DB\u3001\u808C\u8089\u75BC\u75DB\u3001\u5614\u5410\u3001\u8179\u7009\u4EE5\u53CA\u51FA\u75B9\u7B49\u75C7\u72C0\u3002\u75C5\u60C5\u4E4B\u540E\u6703\u9032\u4E00\u6B65\u60E1\u5316\u70BA\u809D\u8870\u7AED\u3001\u814E\u8870\u7AED\uFF0C\u6B65\u5165\u6B64\u968E\u6BB5\uFF0C\u75C5\u4EBA\u6216\u6703\u51FA\u73FE\u9AD4\u5167\u3001\u4F53\u5916\u51FA\u8840\u73FE\u8C61\uFF0C\u4E26\u53EF\u80FD\u5728\u9996\u500B\u75C7\u72C0\u51FA\u73FE\u5F8C\u76846\u81F316\u5929\u5185\u56E0\u8840\u5BB9\u91CF\u904E\u4F4E\u6216\u591A\u91CD\u5668\u5B98\u8870\u7AED\u800C\u6B7B\u4EA1\u3002 \u4F0A\u6CE2\u62C9\u60A3\u8005\u591A\u56E0\u63A5\u89F8\u4E86\u5E36\u6709\u75C5\u6BD2\u7684\u9AD4\u6DB2\uFF08\u5305\u62EC\u8840\u6DB2\uFF09\u3001\u5668\u5B98\uFF0C\u6216\u9593\u63A5\u89F8\u6478\u5230\u6700\u8FD1\u53D7\u6C61\u67D3\u4E4B\u5668\u5177\u800C\u67D3\u75C5\u3002\u76EE\u524D\u5C1A\u672A\u6709\u8DB3\u5920\u7684\u8B49\u64DA\u986F\u793A\u75C5\u6BD2\u80FD\u7D93\u7A7A\u6C23\u5FAE\u7C92\u5728\u9748\u9577\u52D5\u7269\u9593\u50B3\u64AD\u3002\u60A3\u8005\u7684\u7CBE\u6DB2\u6216\u6BCD\u4E73\u5728\u5176\u5EB7\u5FA9\u5F8C\u7684\u6578\u9031\u81F3\u6578\u6708\u5185\uFF0C\u4ECD\u53EF\u80FD\u8F09\u6709\u75C5\u6BD2\u3002\u679C\u8760\u88AB\u8A8D\u70BA\u662F\u57C3\u535A\u62C9\u75C5\u539F\u9AD4\u7684\u5929\u7136\u5BBF\u4E3B\uFF0C\u80FD\u5728\u81EA\u8EAB\u4E0D\u53D7\u5F71\u97FF\u7684\u72C0\u6CC1\u4E0B\u5C07\u4E4B\u6563\u64AD\u3002\u75AB\u75C7\u7684\u63A7\u5236\u5728\u4E8E\u91AB\u7642\u754C\u4EE5\u53CA\u4E00\u5B9A\u7A0B\u5EA6\u7684\u793E\u5340\u914D\u5408\u3002\u524D\u7DDA\u91AB\u5B78\u63AA\u65BD\u5305\u62EC\uFF1A\u5FEB\u901F\u7684\u75C5\u4F8B\u5075\u6E2C\u3001\u5BE6\u9A57\u5BA4\u8A3A\u65B7\u3001\u63A5\u89F8\u8005\u8FFD\u8E64\u3001\u6B63\u78BA\u770B\u8B77\u3001\u8B39\u614E\u8655\u7406\u91AB\u7642\u5EE2\u7269\uFF0C\u4EE5\u53CA\u59A5\u5584\u5B89\u846C\u6216\u706B\u5316\u5C4D\u9AD4\u3002\u6E1B\u5C11\u63A5\u89F8\u53D7\u611F\u67D3\u7684\u500B\u9AD4\u70BA\u793E\u5340\u9632\u75AB\u7684\u4E00\u5927\u91CD\u9EDE\u3002\u5728\u8FD1\u8DDD\u96E2\u63A5\u89F8\u60A3\u8005\u6642\uFF0C\u5E94\u7A7F\u8457\u5B8C\u6574\u7684\u9023\u8EAB\u578B\u9632\u8B77\u8863\u7269\uFF0C\u4E26\u52E4\u52A0\u6D17\u624B\u3002\u53E2\u6797\u8089\u6613\u6CBE\u67D3\u75C5\u6BD2\uFF0C\u6545\u5728\u5FB9\u5E95\u716E\u719F\u5F8C\u65B9\u80FD\u9032\u98DF\uFF1B\u5728\u8655\u7406\u9019\u985E\u7522\u7269\u6642\uFF0C\u4E5F\u9700\u4F69\u6234\u91AB\u7528\u624B\u5957\u3002"@zh , "Penyakit virus ebola (EVD) atau demam berdarah Ebola (EHF) adalah penyakit pada manusia yang disebabkan oleh virus Ebola. Masa inkubasi biasanya dimulai dua hari hingga tiga minggu setelah terjangkit virus, dengan adanya demam, sakit tenggorokan, nyeri otot, dan sakit kepala. Gejala ini biasanya diikuti dengan mual, muntah, dan diare, serta menurunnya fungsi liver dan ginjal. Pada kondisi tersebut, orang yang terpapar virus Ebola mulai mengalami masalah pendarahan."@in , "Ebola gaixotasun birikoa edo ebola sukar hemorragikoa jatorri birikoko gaixotasun kutsakorra da, ebola birusak sortua, gizakiari eta beste primate batzuei eragiten diena. Gizakiarengan gaitza nahiko berria da, lehen kasuak Kongoko Errepublika Demokratikoan eta Sudanen 1976an agertu baitziren. Gaitzaren heriotza-tasa altua da, infektatuen % 50 eta % 90 artean hiltzen baita, birus motaren arabera."@eu , "Gor\u0105czka krwotoczna Ebola, choroba wywo\u0142ana przez wirus Ebola, EHF (od ang. Ebola hemorrhagic fever), EVD (od ang. Ebola virus disease) \u2013 ci\u0119\u017Cka, cz\u0119sto \u015Bmiertelna choroba zaka\u017Ana wywo\u0142ana przez wirus Ebola. Zgodnie z Mi\u0119dzynarodow\u0105 Statystyczn\u0105 Klasyfikacj\u0105 Chor\u00F3b i Problem\u00F3w Zdrowotnych jest zaliczana do kategorii trzyznakowej A98: \u201EInne wirusowe gor\u0105czki krwotoczne niesklasyfikowane gdzie indziej\u201D. Najwi\u0119ksz\u0105 do tej pory epidemi\u0105 tej choroby zar\u00F3wno pod wzgl\u0119dem liczby zachorowa\u0144, jak i liczby przypadk\u00F3w \u015Bmiertelnych, by\u0142a epidemia gor\u0105czki krwotocznej Ebola w Afryce Zachodniej."@pl , "Ebola (t\u00E9\u017E krv\u00E1civ\u00E1 hore\u010Dka ebola) je virov\u00E9 onemocn\u011Bn\u00ED ze skupiny krv\u00E1civ\u00FDch (hemoragick\u00FDch) hore\u010Dek, kter\u00E9 napad\u00E1 lidi a n\u011Bkter\u00E9 dal\u0161\u00ED prim\u00E1ty. P\u0159edstavuje jednu z nejnebezpe\u010Dn\u011Bj\u0161\u00EDch n\u00E1kaz, s jakou se kdy lidstvo setkalo. P\u016Fvodcem onemocn\u011Bn\u00ED je filovirus ebola. Dosud nejv\u011Bt\u0161\u00ED epidemie t\u00E9to nemoci s nejv\u011Bt\u0161\u00EDm po\u010Dtem \u00FAmrt\u00ED propukla v z\u00E1padn\u00ED Africe v prosinci 2013, detekov\u00E1na byla v\u0161ak a\u017E v b\u0159eznu roku 2014. Symptomy se obvykle za\u010D\u00EDnaj\u00ED projevovat n\u011Bkolik dn\u00ED a\u017E t\u0159i t\u00FDdny po n\u00E1kaze virem, a to hore\u010Dkou, bolest\u00ED v krku, a bolest\u00ED hlavy. D\u00E1le typicky n\u00E1sleduje nevolnost, zvracen\u00ED a pr\u016Fjem, spole\u010Dn\u011B se zhor\u0161en\u00FDm fungov\u00E1n\u00EDm jater a ledvin. V t\u00E9to f\u00E1zi za\u010D\u00EDnaj\u00ED m\u00EDt n\u011Bkte\u0159\u00ED lid\u00E9 probl\u00E9my s krv\u00E1cen\u00EDm."@cs , "La maladie \u00E0 virus Ebola, \u00E9galement appel\u00E9e fi\u00E8vre h\u00E9morragique Ebola ou fi\u00E8vre d\u2019Ebola (en anglais : Ebola virus disease ou EVD), est la maladie provoqu\u00E9e par le virus Ebola, qui touche les primates et d'autres animaux tels que le porc. Il s'agit d'une fi\u00E8vre h\u00E9morragique virale aigu\u00EB accompagn\u00E9e d'une atteinte s\u00E9v\u00E8re de l'h\u00E9mostase et du syst\u00E8me immunitaire conduisant \u00E0 une grave immunod\u00E9pression. Pr\u00E9sentant un tableau clinique identique \u00E0 celui des affections \u00E0 virus Marburg, la maladie \u00E0 virus Ebola est r\u00E9put\u00E9e plus grave et le plus souvent mortelle chez l'homme, avec un taux de l\u00E9talit\u00E9 atteignant parfois 90 % lors des flamb\u00E9es \u00E9pid\u00E9miques. Ces derni\u00E8res surviennent principalement dans les villages isol\u00E9s d'Afrique centrale et d'Afrique de l'Ouest, \u00E0 proximit\u00E9 des for\u00EAts de feuillus h"@fr , "\u0397 \u039D\u03CC\u03C3\u03BF\u03C2 \u03C4\u03BF\u03C5 \u0388\u03BC\u03C0\u03BF\u03BB\u03B1 (EVD) \u03AE \u03B1\u03B9\u03BC\u03BF\u03C1\u03C1\u03B1\u03B3\u03B9\u03BA\u03CC\u03C2 \u03C0\u03C5\u03C1\u03B5\u03C4\u03CC\u03C2 \u0388\u03BC\u03C0\u03BF\u03BB\u03B1 (EHF) \u03B5\u03AF\u03BD\u03B1\u03B9 \u03BC\u03B9\u03B1 \u03B1\u03BD\u03B8\u03C1\u03CE\u03C0\u03B9\u03BD\u03B7 \u03BD\u03CC\u03C3\u03BF\u03C2 \u03C0\u03BF\u03C5 \u03C0\u03C1\u03BF\u03BA\u03B1\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03BF\u03BD . \u03A4\u03B1 \u03C3\u03C5\u03BC\u03C0\u03C4\u03CE\u03BC\u03B1\u03C4\u03B1 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B4\u03CD\u03BF \u03BC\u03AD\u03C1\u03B5\u03C2 \u03AD\u03C9\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03C1\u03B5\u03B9\u03C2 \u03B5\u03B2\u03B4\u03BF\u03BC\u03AC\u03B4\u03B5\u03C2 \u03BC\u03B5\u03C4\u03AC \u03C4\u03B7\u03BD \u03B5\u03C0\u03B1\u03C6\u03AE \u03BC\u03B5 \u03C4\u03BF\u03BD \u03B9\u03CC \u03BA\u03B1\u03B9 \u03C3\u03B5 \u03B1\u03C5\u03C4\u03AC \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C0\u03C5\u03C1\u03B5\u03C4\u03CC\u03C2, \u03C0\u03BF\u03BD\u03CC\u03BB\u03B1\u03B9\u03BC\u03BF\u03C2, \u03BA\u03B1\u03B9 \u03C0\u03BF\u03BD\u03BF\u03BA\u03AD\u03C6\u03B1\u03BB\u03BF\u03C2. \u03A3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2, \u03C3\u03C5\u03BD\u03BF\u03B4\u03B5\u03CD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03BD\u03B1\u03C5\u03C4\u03AF\u03B1, \u03B5\u03BC\u03B5\u03C4\u03CC \u03BA\u03B1\u03B9 \u03B4\u03B9\u03AC\u03C1\u03C1\u03BF\u03B9\u03B1, \u03BA\u03B1\u03B9 \u03C4\u03B1\u03C5\u03C4\u03CC\u03C7\u03C1\u03BF\u03BD\u03B1 \u03BC\u03B5\u03B9\u03C9\u03BC\u03AD\u03BD\u03B7 \u03BB\u03B5\u03B9\u03C4\u03BF\u03C5\u03C1\u03B3\u03AF\u03B1 \u03C4\u03BF\u03C5 \u03C3\u03C5\u03BA\u03C9\u03C4\u03B9\u03BF\u03CD \u03BA\u03B1\u03B9 \u03C4\u03BF\u03C5/\u03C4\u03C9\u03BD \u03BD\u03B5\u03C6\u03C1\u03BF\u03CD/\u03CE\u03BD. \u03A3\u03B5 \u03B1\u03C5\u03C4\u03CC \u03C4\u03BF \u03C3\u03C4\u03AC\u03B4\u03B9\u03BF, \u03BF\u03C1\u03B9\u03C3\u03BC\u03AD\u03BD\u03B1 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03B1\u03C1\u03C7\u03AF\u03B6\u03BF\u03C5\u03BD \u03BD\u03B1 \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03C5\u03BD \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03B1\u03B9\u03BC\u03BF\u03C1\u03C1\u03B1\u03B3\u03AF\u03B1\u03C2."@el , "A doen\u00E7a por v\u00EDrus \u00C9bola (DVE), tamb\u00E9m denominada no Brasil por doen\u00E7a por v\u00EDrus ebola, \u00E9 uma doen\u00E7a infeciosa causada pelo v\u00EDrus \u00C9bola que afeta seres humanos e outros mam\u00EDferos. Os sintomas t\u00EAm in\u00EDcio de duas a tr\u00EAs semanas ap\u00F3s contrair o v\u00EDrus, manifestando-se inicialmente por febre, garganta inflamada, dores musculares e dores de cabe\u00E7a. Estes sintomas s\u00E3o seguidos por v\u00F3mitos, diarreia e exantema, a par de insufici\u00EAncia hep\u00E1tica e renal. Nesta fase, a pessoa infetada pode apresentar hemorragias internas e externas. Em caso de morte, esta geralmente ocorre entre 6 a 16 dias ap\u00F3s o in\u00EDcio dos sintomas e na maior parte dos casos deve-se \u00E0 diminui\u00E7\u00E3o da press\u00E3o arterial resultante da perda de sangue."@pt , "\u30A8\u30DC\u30E9\u51FA\u8840\u71B1\uFF08\u30A8\u30DC\u30E9\u3057\u3085\u3063\u3051\u3064\u306D\u3064\u3001Ebola hemorrhagic fever; EHF\uFF09\u3001\u307E\u305F\u306F\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u75C5\uFF08\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u3073\u3087\u3046\u3001Ebola virus disease; EVD\uFF09\u306F\u3001\u30D5\u30A3\u30ED\u30A6\u30A4\u30EB\u30B9\u79D1\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u5C5E\u306E\u30A6\u30A4\u30EB\u30B9\u3092\u75C5\u539F\u4F53\u3068\u3059\u308B\u6025\u6027\u30A6\u30A4\u30EB\u30B9\u6027\u611F\u67D3\u75C7\u3002\u30DE\u30FC\u30EB\u30D6\u30EB\u30B0\u75C5\u3001\u30E9\u30C3\u30B5\u71B1\u3001\u5357\u7C73\u51FA\u8840\u71B1\u3001\u30AF\u30EA\u30DF\u30A2\u30FB\u30B3\u30F3\u30B4\u51FA\u8840\u71B1\u3068\u4E26\u3076\u3001\u30A6\u30A4\u30EB\u30B9\u6027\u51FA\u8840\u71B1\u306E1\u3064\u3060\u304C\u3001\u611F\u67D3\u8005\u304C\u5FC5\u305A\u3057\u3082\u51FA\u8840\u75C7\u72B6\u3092\u5448\u3059\u308B\u308F\u3051\u3067\u306F\u306A\u3044\u305F\u3081\u3001\u56FD\u969B\u7684\u306B\u306F\u547C\u79F0\u304C\u30A8\u30DC\u30E9\u51FA\u8840\u71B1\u304B\u3089\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u75C5\u3078\u5207\u308A\u66FF\u308F\u308A\u3064\u3064\u3042\u308B\u3002\u4E3B\u306B\u30A2\u30D5\u30EA\u30AB\u3067\u767A\u751F\u3059\u308B\u3002 \u30D2\u30C8\u306B\u611F\u67D3\u3057\u3001\u6CBB\u7642\u958B\u59CB\u304C\u9045\u308C\u308B\u3068\u81F4\u6B7B\u7387\u306F80 - 90%\u306B\u4E0A\u308B\uFF08\u30A6\u30A4\u30EB\u30B9\u306B\u3088\u3063\u3066\u7570\u306A\u308B\uFF09\u3002\u307E\u305F\u3001\u4EEE\u306B\u6551\u547D\u3067\u304D\u305F\u3068\u3057\u3066\u3082\u91CD\u7BE4\u306A\u5F8C\u907A\u75C7\u3092\u6B8B\u3059\u3053\u3068\u304C\u3042\u308A\u3001\u30EA\u30B9\u30AF\u30B0\u30EB\u30FC\u30D7\u30EC\u30D9\u30EB4\u30A6\u30A4\u30EB\u30B9\u306E\u4E00\u3064\u3067\u3042\u308B\u3002\u4E00\u65B9\u3001\u6BD2\u6027\u3084\u81F4\u6B7B\u7387\u304C\u3042\u307E\u308A\u306B\u3082\u9AD8\u304F\u3001\u9060\u51FA\u3059\u308B\u6A5F\u4F1A\u3092\u5F97\u308B\u524D\u306B\u60A3\u8005\u304C\u6B7B\u4EA1\u3057\u3066\u3057\u307E\u3046\u3053\u3068\u304C\u5C02\u3089\u3067\u3042\u308B\u3053\u3068\u304B\u3089\u3001\u4E16\u754C\u7684\u6D41\u884C\u306B\u306F\u81F3\u3063\u3066\u3044\u306A\u3044\uFF08\u3053\u308C\u304C\u81F4\u6B7B\u7387\u304C\u6BD4\u8F03\u7684\u4F4E\u3044\u305F\u3081\u8EFD\u75C7\u306E\u60A3\u8005\u304C\u9060\u51FA\u3057\u3084\u3059\u304F\u4E16\u754C\u7684\u5927\u6D41\u884C\u3092\u5F15\u304D\u8D77\u3053\u3057\u305F\u65B0\u578B\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u3084\u65B0\u578B\u30B3\u30ED\u30CA\u30A6\u30A4\u30EB\u30B9\u611F\u67D3\u75C7\u3068\u306E\u9055\u3044\u3067\u3042\u308B\uFF09\u3002 2019\u5E747\u6708\u3001WHO\u306F\u30B3\u30F3\u30B4\u6C11\u4E3B\u5171\u548C\u56FD\u3067\u306E\u5927\u6D41\u884C\u306B\u3064\u3044\u3066\u300C\u56FD\u969B\u7684\u306B\u61F8\u5FF5\u3055\u308C\u308B\u516C\u8846\u885B\u751F\u4E0A\u306E\u7DCA\u6025\u4E8B\u614B(PHEIC)\u300D\u306B\u6307\u5B9A\u3057\u305F\u3002"@ja , "\u0411\u043E\u043B\u0435\u0437\u043D\u044C, \u0432\u044B\u0437\u0432\u0430\u043D\u043D\u0430\u044F \u0432\u0438\u0440\u0443\u0441\u043E\u043C \u042D\u0431\u043E\u0301\u043B\u0430 (\u0411\u0412\u0412\u042D, \u0430\u043D\u0433\u043B. Ebola virus disease, EVD), \u0442\u0430\u043A\u0436\u0435 \u0438\u0437\u0432\u0435\u0441\u0442\u043D\u0430\u044F \u043A\u0430\u043A \u0433\u0435\u043C\u043E\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043B\u0438\u0445\u043E\u0440\u0430\u0434\u043A\u0430 \u042D\u0431\u043E\u0301\u043B\u0430 (\u0430\u043D\u0433\u043B. Ebola Haemorrhagic Fever, EHF, \u043B\u0430\u0442. Ebola febris haemorrhagica) \u2014 \u043E\u0441\u0442\u0440\u0430\u044F \u0432\u0438\u0440\u0443\u0441\u043D\u0430\u044F \u0432\u044B\u0441\u043E\u043A\u043E\u043A\u043E\u043D\u0442\u0430\u0433\u0438\u043E\u0437\u043D\u0430\u044F \u0431\u043E\u043B\u0435\u0437\u043D\u044C. \u0420\u0435\u0434\u043A\u043E\u0435, \u043D\u043E \u043A\u0440\u0430\u0439\u043D\u0435 \u043E\u043F\u0430\u0441\u043D\u043E\u0435 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0435. \u0412\u0441\u043F\u044B\u0448\u043A\u0438 \u044D\u043F\u0438\u0434\u0435\u043C\u0438\u0438 \u0437\u0430\u0444\u0438\u043A\u0441\u0438\u0440\u043E\u0432\u0430\u043D\u044B \u0432 \u0426\u0435\u043D\u0442\u0440\u0430\u043B\u044C\u043D\u043E\u0439 \u0438 \u0417\u0430\u043F\u0430\u0434\u043D\u043E\u0439 \u0410\u0444\u0440\u0438\u043A\u0435, \u043B\u0435\u0442\u0430\u043B\u044C\u043D\u043E\u0441\u0442\u044C \u0441\u043E\u0441\u0442\u0430\u0432\u043B\u044F\u043B\u0430 \u043E\u0442 25 \u0434\u043E 90 % (\u0432 \u0441\u0440\u0435\u0434\u043D\u0435\u043C 50 %). \u0411\u043E\u043B\u0435\u0437\u043D\u044C \u043F\u043E\u0440\u0430\u0436\u0430\u0435\u0442 \u0442\u043E\u043B\u044C\u043A\u043E \u0447\u0435\u043B\u043E\u0432\u0435\u043A\u0430, \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0445 \u043F\u0440\u0438\u043C\u0430\u0442\u043E\u0432, \u0430 \u0442\u0430\u043A\u0436\u0435 \u043F\u0430\u0440\u043D\u043E\u043A\u043E\u043F\u044B\u0442\u043D\u044B\u0445 (\u0432 \u0447\u0430\u0441\u0442\u043D\u043E\u0441\u0442\u0438, \u043F\u043E\u0434\u0442\u0432\u0435\u0440\u0436\u0434\u0435\u043D\u044B \u0441\u043B\u0443\u0447\u0430\u0438 \u043F\u043E\u0440\u0430\u0436\u0435\u043D\u0438\u044F \u0441\u0432\u0438\u043D\u0435\u0439 \u0438 \u0434\u0443\u043A\u0435\u0440\u043E\u0432)."@ru , "\u0425\u0432\u043E\u0440\u043E\u0301\u0431\u0430, \u044F\u043A\u0443 \u0441\u043F\u0440\u0438\u0447\u0438\u0301\u043D\u044E\u0454 \u0432\u0456\u0301\u0440\u0443\u0441 \u0415\u0301\u0301\u0431\u043E\u0301\u043B\u0430 (\u0433\u0430\u0440\u044F\u0447\u043A\u0430 \u0415\u0431\u043E\u043B\u0430, \u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u0430 \u0433\u0430\u0440\u044F\u0447\u043A\u0430 \u0415\u0431\u043E\u043B\u0430, \u0430\u043D\u0433\u043B. Ebola fever, \u043B\u0430\u0442. febris Ebola) \u2014 \u0433\u043E\u0441\u0442\u0440\u0430 \u0432\u0456\u0440\u0443\u0441\u043D\u0430 \u0432\u0438\u0441\u043E\u043A\u043E\u043A\u043E\u043D\u0442\u0430\u0433\u0456\u043E\u0437\u043D\u0430 \u043F\u0440\u0438\u0440\u043E\u0434\u043D\u043E-\u043E\u0441\u0435\u0440\u0435\u0434\u043A\u043E\u0432\u0430 \u0445\u0432\u043E\u0440\u043E\u0431\u0430, \u044F\u043A\u0430 \u0445\u0430\u0440\u0430\u043A\u0442\u0435\u0440\u0438\u0437\u0443\u0454\u0442\u044C\u0441\u044F \u0447\u0430\u0441\u0442\u043E \u0442\u044F\u0436\u043A\u0438\u043C \u043F\u0435\u0440\u0435\u0431\u0456\u0433\u043E\u043C, \u0432\u0438\u0441\u043E\u043A\u043E\u044E \u043B\u0435\u0442\u0430\u043B\u044C\u043D\u0456\u0441\u0442\u044E, \u0432\u0438\u0440\u0430\u0436\u0435\u043D\u043E\u044E \u0456\u043D\u0442\u043E\u043A\u0441\u0438\u043A\u0430\u0446\u0456\u0454\u044E, \u0437\u043D\u0435\u0432\u043E\u0434\u043D\u0435\u043D\u043D\u044F\u043C, \u0443\u0440\u0430\u0436\u0435\u043D\u043D\u044F\u043C \u043A\u0440\u043E\u0432\u043E\u043D\u043E\u0441\u043D\u0438\u0445 \u0441\u0443\u0434\u0438\u043D \u0431\u0430\u0433\u0430\u0442\u044C\u043E\u0445 \u043E\u0440\u0433\u0430\u043D\u0456\u0432 \u0456\u0437 \u0440\u043E\u0437\u0432\u0438\u0442\u043A\u043E\u043C \u0442\u044F\u0436\u043A\u043E\u0433\u043E \u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u0441\u0438\u043D\u0434\u0440\u043E\u043C\u0443."@uk , "Ebola hemoragia febro a\u016D Ebola virusa malsano estas malsano de homoj kaj aliaj primatoj ka\u016Dzita de la Ebolo. Simptomoj montri\u011Das de du tagoj \u011Dis tri semajnoj post infekti\u011Do. Tipaj simptomoj inkluzivas febron, gor\u011Do-doloron, muskolan doloron, kaj kapdoloron. Vomado, erupcioj, kaj diareo sekvas, kune kun difekti\u011Do de la hepato kaj renoj. Proksimume samtempe, infektataj homoj komencos sangi, kaj interne kaj ekstere."@eo , "( \uC5D0\uBCFC\uB77C\uB294 \uC5EC\uAE30\uB85C \uC5F0\uACB0\uB429\uB2C8\uB2E4. \uB2E4\uB978 \uB73B\uC5D0 \uB300\uD574\uC11C\uB294 \uC5D0\uBCFC\uB77C (\uB3D9\uC74C\uC774\uC758) \uBB38\uC11C\uB97C \uCC38\uACE0\uD558\uC2ED\uC2DC\uC624.) \uC5D0\uBCFC\uB77C \uCD9C\uD608\uC5F4(Ebola hemorrhagic fever; EHF) \uB610\uB294 \uC5D0\uBCFC\uB77C\uBC14\uC774\uB7EC\uC2A4\uBCD1(Ebola virus disease; EVD)\uB294 \uBC14\uC774\uB7EC\uC2A4\uC131 \uCD9C\uD608\uC5F4 \uC911 \uD558\uB098\uC774\uBA70, \uC5D0\uBCFC\uB77C \uBC14\uC774\uB7EC\uC2A4\uB85C \uC778\uD574 \uC77C\uC5B4\uB098\uB294 \uC778\uAC04\uC758 \uC9C8\uBCD1\uC774\uB2E4. \uC99D\uC0C1\uC758 \uC7A0\uBCF5\uAE30\uB294 \uBC14\uC774\uB7EC\uC2A4 \uAC10\uC5FC \uC774\uD6C4 \uC774\uD2C0\uBD80\uD130 \uC0BC\uC8FC\uAE4C\uC9C0 \uC9C0\uC18D\uB418\uBA70 \uBC1C\uC5F4, \uBAA9\uACFC \uADFC\uC721\uC758 \uD1B5\uC99D, \uB450\uD1B5\uC744 \uB3D9\uBC18\uD55C\uB2E4. \uC774\uD6C4 \uD1B5\uC0C1\uC801\uC73C\uB85C \uAD6C\uC5ED\uC9C8, \uAD6C\uD1A0, \uC124\uC0AC\uC640 \uD568\uAED8 \uAC04\uACFC \uCF69\uD325 \uAE30\uB2A5\uC758 \uC545\uD654 \uC99D\uC0C1\uC774 \uB098\uD0C0\uB09C\uB2E4. \uC774 \uC2DC\uC810\uC5D0\uC11C \uBA87\uBA87 \uC0AC\uB78C\uB4E4\uC740 \uCD9C\uD608 \uC99D\uC0C1\uC774 \uB098\uD0C0\uB098\uAE30\uB3C4 \uD55C\uB2E4. \uCCB4\uC561\uC73C\uB85C \uAC10\uC5FC\uB418\uB294 \uAC10\uC5FC\uBCD1 \uC911\uC5D0\uC11C\uB294 \uC804\uC5FC\uB825\uC774 \uB9E4\uC6B0 \uAC15\uD55C \uC9C8\uBCD1\uC774\uBA70 \uCE58\uC0AC\uC728\uB3C4 \uB192\uB2E4. \uC5D0\uBCFC\uB77C \uD658\uC790 \uCE58\uB8CC\uACBD\uD5D8\uC774 \uAC00\uC7A5 \uB9CE\uC740 \uC758\uC0AC\uC778 \uC170\uC774\uD06C \uC6B0\uB9C8\uB974 \uCE78 \uBC15\uC0AC\uB97C \uBE44\uB86F\uD558\uC5EC \uC804 \uC138\uACC4\uC5D0\uC11C \uC758\uB8CC\uC778 184\uBA85\uC774 \uAC10\uC5FC\uB410\uACE0 \uADF8 \uC911 \uC808\uBC18\uC774 \uC0AC\uB9DD\uD588\uB2E4.\uC138\uACC4\uBCF4\uAC74\uAE30\uAD6C\uC5D0\uC11C\uB294 \uC5D0\uBCFC\uB77C\uAC00 \uACF5\uAE30\uB85C \uC804\uC5FC\uB418\uC9C0 \uC54A\uC73C\uBA70 \uCCB4\uC561\uC73C\uB85C\uB9CC \uC804\uC5FC\uB41C\uB2E4\uACE0 \uBC1C\uD45C\uD588\uC9C0\uB9CC, \uACF5\uAE30 \uC804\uC5FC\uC758 \uAC00\uB2A5\uC131\uC774 \uC788\uB2E4\uB294 \uC804\uBB38\uAC00\uB4E4\uC758 \uC758\uACAC\uC774 \uC788\uB2E4. \uAC10\uC5FC\uC790\uB85C\uBD80\uD130 1m \uC774\uC0C1 \uB5A8\uC5B4\uC9C0\uBA74 \uC0C1\uB300\uC801\uC73C\uB85C \uC548\uC804\uD55C \uAC83\uC73C\uB85C \uC54C\uB824\uC838 \uC788\uB2E4."@ko , "Ebola, f\u00F6rkortat EVD (Ebola Virus Disease), \u00E4r en epidemisk sjukdom som orsakas av ebolavirus. Namnet kommer fr\u00E5n Ebolafloden i Demokratiska Republiken Kongo, d\u00E4r de f\u00F6rsta utbrotten \u00E4gde rum 1976, samtidigt med utbrott i Nzara i Sudan. Ebolafebern \u00E4r en bl\u00F6darfeber d\u00E4r viruset p\u00E5verkar endotelcellerna i blodk\u00E4rlen och minskar koagulationsf\u00F6rm\u00E5gan, vilket leder till att blod l\u00E4cker ur blodk\u00E4rlen och kroppen hamnar i hypovolemisk chock (cirkulationssvikt). Sjukdomen smittar via kroppsv\u00E4tskor och \u00E4r mycket d\u00F6dlig. Virusstammen Ebola zaire har en d\u00F6dlighet p\u00E5 80 procent."@sv , "La malattia da virus Ebola (in inglese Ebolavirus disease - EVD), precedentemente conosciuta come febbre emorragica Ebola (Ebola haemorrhagic fever - EHF) \u00E8 una febbre emorragica degli esseri umani e di altri primati causata dal virus Ebola; \u00E8 stata identificata per la prima volta in Sudan e nella Repubblica Democratica del Congo. La malattia si verifica in genere in focolai epidemici che interessano regioni tropicali dell'Africa sub-sahariana. A causa della carenza di strumentario appropriato e di protocolli igienico-sanitari, le epidemie su vasta scala scoppiano con pi\u00F9 facilit\u00E0 nelle aree pi\u00F9 povere ed isolate prive di ospedali moderni e di personale addestrato."@it , "Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after becoming infected with the virus. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point, some people begin to bleed both internally and externally. The disease kills between 25% and 90% of those infected \u2013 about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear. Early treatment of symptoms increases the survival rate considerably compa"@en ; rdfs:seeAlso dbr:Cultural_effects_of_the_Ebola_crisis . @prefix foaf: . dbr:Ebola foaf:homepage . @prefix dbp: . dbr:Ebola dbp:name "Ebola"@en ; foaf:depiction , , , , , , , , , , , , , , , . @prefix dcterms: . @prefix dbc: . dbr:Ebola dcterms:subject dbc:Articles_containing_video_clips , dbc:Health_in_Africa , dbc:Animal_viral_diseases , dbc:Bat_virome , dbc:West_African_Ebola_virus_epidemic , dbc:Wikipedia_infectious_disease_articles_ready_to_translate , dbc:Sexually_transmitted_diseases_and_infections , dbc:Biological_weapons , dbc:Virus-related_cutaneous_conditions , dbc:Arthropod-borne_viral_fevers_and_viral_haemorrhagic_fevers , dbc:Ebola , dbc:Wikipedia_pages_referenced_by_the_press , dbc:Zoonoses , dbc:Hemorrhagic_fevers , dbc:Wikipedia_medicine_articles_ready_to_translate , dbc:Tropical_diseases ; dbo:wikiPageID 40817590 ; dbo:wikiPageRevisionID 1124599844 ; dbo:wikiPageWikiLink dbr:Dehydration , dbr:Nucleocapsid , dbr:Scientific_American , dbr:RVSV-ZEBOV , dbr:Epomops_franqueti , dbr:Candidiasis , dbr:Lyon , dbr:Diarrhoea , dbr:Endothelial_cells , dbr:Real-time_PCR , dbr:Filoviruses , dbr:Cremation , dbr:Bioterrorism , dbr:Thrombocytopenia , , dbr:Sub-Saharan_Africa , dbr:Packed_red_blood_cells , dbr:DC-SIGN , dbr:Intensive_care , dbr:RIG-I , dbr:Histoplasmosis , dbr:Republic_of_the_Congo , dbr:World_Health_Organization , dbr:Public_Health_Emergency_of_International_Concern , dbc:Health_in_Africa , dbr:Myalgia , dbr:Genome , dbr:Goma , dbr:Bundibugyo_District , dbr:Interferon-beta , dbr:Reverse_transcription_polymerase_chain_reaction , dbr:IFNAR1 , dbr:Mabalo_Lokela , dbr:Crab-eating_macaque , dbr:Shigellosis , , dbc:Animal_viral_diseases , dbr:Ecchymosis , dbr:Sudan , dbr:Nina_Pham , dbr:Primate , dbr:Monocyte , dbr:Monrovia , dbr:Biological_warfare , dbr:Public_health_emergency_of_international_concern , dbr:Viral_haemorrhagic_fevers , dbr:Needlestick_injury , dbr:Duikers , dbr:Bellevue_Hospital , dbr:Viral_latency , , dbr:Interferon_gamma , dbr:Abidjan , dbr:The_Democratic_Republic_of_the_Congo , dbr:Kawasaki_disease , dbr:Blood_vessel , dbr:Coagulation_cascade , , dbr:Scrub_typhus , dbr:Calcium_hypochlorite , dbc:Bat_virome , dbr:Borreliosis , dbr:RAF_Northolt , , dbr:Anxiolytic , dbr:Cell_culture , dbr:Purpura , dbr:Leptospirosis , dbr:Nzara , dbc:West_African_Ebola_virus_epidemic , , dbr:Gastrointestinal_tract , dbr:Glycoprotein , , dbr:Adrenal_gland , dbr:Tom_Clancy , , dbr:Kidney , dbr:Pain_management , , dbr:Middle_East , dbr:Trypanosomiasis , dbr:Simian_haemorrhagic_fever_virus , dbr:Primates , dbr:STAT2 , dbr:Disinfectants , , , dbr:Nucleic_acid_sequence , dbr:Miscarriage , dbr:Sepsis , dbr:Symptoms , dbr:Saliva , dbr:White_blood_cell , dbr:Detergents , , dbr:Integrin , , dbr:Guinea , dbr:Toll-like_receptor_3 , dbr:Quinine , dbr:Nosocomial , dbr:Hypovolemic_shock , dbr:Typhoid_fever , dbr:Toll-like_receptor_9 , dbr:Sylvisorex_ollula , dbr:Antiemetic , dbc:Wikipedia_infectious_disease_articles_ready_to_translate , dbr:Antibodies , dbr:STAT1 , dbr:Personal_protective_equipment , dbr:Quarantine , dbr:Marburg_virus_disease , dbr:Immunoglobulin_G , dbc:Sexually_transmitted_diseases_and_infections , dbr:Bush_meat , dbr:Haemodialysis , dbr:Centers_for_Disease_Control , dbr:Biological_life_cycle , , dbr:Coagulopathy , dbr:Endosome , dbr:Praomys , dbr:Liberia , dbr:Hiccups , dbr:Coagulation_factors , dbr:Cell_membrane , dbr:Semen , dbr:Bat , dbr:Haematemesis , dbr:Cell_nucleus , dbr:Platelet , dbr:Bundibugyo_virus , dbr:Blood , dbr:Atlanta , dbr:Body_fluid , dbr:Rickettsia , dbr:Disseminated_intravascular_coagulation , dbr:Cytokine_storm , dbr:Cell_surface_receptor , dbr:Visceral , dbr:Alanine_aminotransferase , dbr:Gabon , dbr:Antelope , dbc:Biological_weapons , dbr:Enzyme-linked_immunosorbent_assay , dbr:Bibliography_of_Ebola , dbr:Menstrual_period , , dbr:Euthanisia , dbr:Kidney_failure , dbr:Bombali_ebolavirus , dbr:Q_fever , dbr:Immunoglobulin_M , dbr:Ebola_River , dbr:Coagulation , , dbr:Organ-on-a-chip , dbr:MDA5 , dbr:Ebola_virus_disease_treatment_research , dbr:Protein_dimer , dbr:Vision_loss , dbr:Ebolavirus , dbr:Fever , dbr:Bleeding , dbr:Acute_promyelocytic_leukaemia , dbr:Viral_hemorrhagic_fever , dbr:Viral_hepatitis , dbr:Influenza , dbr:Three_prime_untranslated_region , dbr:Antimalarial_medication , dbr:Tissue_factor , dbr:Oedema , dbr:Subconjunctival_haemorrhage , dbr:Leucocytosis , dbr:Ebola_vaccine , dbr:Lymph_node , dbr:High-level_isolation_unit , dbr:Bleeding_time , dbr:Ebola_virus , , dbr:Case_fatality_rate , dbr:Burial_ritual , dbr:Myonycteris_torquata , dbc:Virus-related_cutaneous_conditions , dbr:Lymphocytopenia , dbr:Hyperlacrimation , , dbr:Alopecia , dbr:Great_apes , dbr:Cytosol , dbr:Sierra_Leone , dbr:Supportive_care , dbr:Haematoma , dbr:List_of_Ebola_outbreaks , dbr:Wangata , dbr:Mus_setulosus , dbr:Vomiting , dbr:Reston_virus , dbr:London , dbr:US_Army , dbr:Malaria , dbr:Pathogen , dbr:Pathogen-associated_molecular_pattern , dbr:Jean-Jacques_Muyembe-Tamfum , dbr:Bangladesh , dbr:Weapon_of_mass_destruction , dbr:Dengue_fever , , dbr:Central_African_Republic , , dbr:Dendritic_cell , dbr:Haemoptysis , dbr:Reston_ebolavirus , dbr:West_Africa_Ebola_virus_outbreak , , dbr:Photophobia , dbr:Decreased_level_of_consciousness , dbr:Shortness_of_breath , dbr:C-type_lectin , dbr:Baboon , dbr:Marburg_virus , dbr:United_States_Army_Medical_Research_Institute_of_Infectious_Diseases , dbr:Bleeding_disorder , dbr:Contact_tracing , dbr:Marburgvirus , dbr:Headache , dbr:Thrombotic_thrombocytopenic_purpura , dbr:Food_and_Drug_Administration , dbr:RNA , dbr:Headaches , dbr:Mononuclear_phagocyte_system , dbc:Ebola , dbr:Filoviridae , , , dbr:Shrew , dbr:Petechia , dbr:Best-selling , , dbr:Peter_Piot , dbr:Orchitis , dbr:Seroprevalence , dbr:Zaire_ebolavirus , dbr:Biosafety_level_4 , dbr:Hepatitis , dbc:Arthropod-borne_viral_fevers_and_viral_haemorrhagic_fevers , dbr:Ibuprofen , dbr:Mbandaka , dbr:Chlorine_powder , , dbr:Lymphatic_system , , dbr:Yambuku , , dbr:ELISA , dbr:Zaire , dbr:Measles , dbr:Feces , dbr:Bikoro , dbr:Lymphocyte , dbr:Warfarin , dbr:Toll-like_receptor_7 , dbr:Palliative_care , dbr:Toll-like_receptor_8 , dbr:Interferome , dbr:Epidemiologist , dbr:Gorilla , dbr:Snake_envenomation , dbr:Uganda , dbr:Antibiotics , dbr:Hand_washing , dbr:Bushmeat , dbc:Wikipedia_pages_referenced_by_the_press , dbr:Verotoxin-producing_Escherichia_coli , dbr:Interferon-alpha , dbr:Seroconversion , dbr:Fibroblast , dbr:Intravenous_therapy , dbr:The_Hot_Zone , dbr:Mongala_District , dbr:Lassa_fever , dbr:Index_case , dbr:Rodent , dbr:Polymerase_chain_reaction , dbr:Richard_Preston , dbr:Megabat , dbr:Breast_milk , dbr:Gene , dbr:Scavenge , dbr:List_of_distinct_cell_types_in_the_adult_human_body , dbr:Haemolytic_uraemic_syndrome , , dbr:Differential_diagnosis , dbr:Sodium_hypochlorite , dbr:Sudan_virus , dbr:Gartnavel_General_Hospital , dbr:Innate_immune_system , dbr:Antipyretic , dbr:Pandemics , dbr:Heparin , dbr:Natural_host , dbr:South_Sudan , dbr:Isiro , dbc:Zoonoses , dbr:Maculopapular_rash , dbr:Chest_pain , dbr:Arthralgia . @prefix ns10: . dbr:Ebola dbo:wikiPageWikiLink ns10:odesivimab , dbr:Leucopenia , dbr:MRNA , dbr:Fresh_frozen_plasma , dbr:Intravenous_fluids , dbr:Sexual_intercourse , dbr:William_Close , dbr:Asthenia , , dbr:Deforestation_in_the_Democratic_Republic_of_the_Congo , dbr:Partial_thromboplastin_time , dbr:Pinocytosis , dbr:Hepatocyte , dbc:Hemorrhagic_fevers , dbr:Democratic_Republic_of_the_Congo , dbr:Budding , dbr:Biopreparat , dbr:Pauline_Cafferkey , dbr:RNA-dependent_RNA_polymerase , dbr:Natural_reservoir , dbr:Martial_law , dbr:IFNAR2 , dbr:Extracorporeal_membrane_oxygenation , dbr:Hereditary_haemorrhagic_telangiectasia , dbr:Executive_Orders , dbr:Five_prime_untranslated_region , , dbr:Oral_rehydration_therapy , dbr:Doctors_Without_Borders , dbr:Embalming , dbr:Neutrophils , dbr:Filovirus , dbr:Glasgow , dbr:Royal_Free_Hospital , dbr:Disinfection , dbc:Wikipedia_medicine_articles_ready_to_translate , dbr:Interferon_Regulatory_Factor_3 , dbr:Sore_throat , dbr:Tissue_factor_pathway , dbr:Meningitis , dbr:Blood_in_stool , dbr:Kinshasa , dbr:EBOV , , dbr:Ebola_virus_epidemic_in_West_Africa , dbr:Tedros_Adhanom_Ghebreyesus , , , dbr:Hypsignathus_monstrosus , dbr:Internal_bleeding , , dbr:Arthropod , , dbr:Uveitis , , dbr:Leishmaniasis , dbr:Electron_microscopy , dbr:Incubation_period , dbr:Coma , dbr:Aspirin , dbr:Interferon_regulatory_factor-7 , dbr:West_African_Ebola_virus_epidemic , dbr:Aspartate_aminotransferase , dbr:Liver , dbr:Biosafety_level , dbr:Whole_genome_sequencing , dbr:Chimpanzee , dbr:Rash , dbr:Equateur , , dbr:Desquamation , dbc:Tropical_diseases , dbr:Genus , dbr:Ansuvimab , dbr:Washing_hands , dbr:Macrophage , dbr:Centers_for_Disease_Control_and_Prevention , dbr:Mobutu_Sese_Seko , , dbr:Apoptosis , dbr:Prothrombin_time , dbc:Articles_containing_video_clips , dbr:North_Kivu , dbr:Lysosome , dbr:Cholera , dbr:Type_1_interferon ; dbo:wikiPageExternalLink , , . @prefix ns11: . dbr:Ebola dbo:wikiPageExternalLink ns11:ebola-preparedness-and-response-updates-fda , , , , , , , , ; owl:sameAs , , . @prefix dbpedia-de: . dbr:Ebola owl:sameAs dbpedia-de:Ebolafieber , , , . @prefix dbpedia-cy: . dbr:Ebola owl:sameAs dbpedia-cy:Clefyd_firaol_ebola , , , , . @prefix dbpedia-sw: . dbr:Ebola owl:sameAs dbpedia-sw:Ebola , . @prefix dbpedia-eo: . dbr:Ebola owl:sameAs dbpedia-eo:Ebola_malsano . @prefix dbpedia-sl: . dbr:Ebola owl:sameAs dbpedia-sl:Ebola , . @prefix ns17: . dbr:Ebola owl:sameAs ns17:Panyakit_ebola . @prefix dbpedia-simple: . dbr:Ebola owl:sameAs dbpedia-simple:Ebola_virus_disease . @prefix dbpedia-eu: . dbr:Ebola owl:sameAs dbpedia-eu:Ebola_gaixotasun_biriko , . @prefix dbpedia-da: . dbr:Ebola owl:sameAs dbpedia-da:Ebola , , , , , . @prefix dbpedia-sh: . dbr:Ebola owl:sameAs dbpedia-sh:Ebola , , , , , , , , . @prefix dbpedia-af: . dbr:Ebola owl:sameAs dbpedia-af:Ebola . @prefix dbpedia-oc: . dbr:Ebola owl:sameAs dbpedia-oc:Virus_Ebola , . @prefix ns24: . dbr:Ebola owl:sameAs ns24:Ebola_gemorragik_isitmasi . @prefix dbpedia-nl: . dbr:Ebola owl:sameAs dbpedia-nl:Ebola , , , . @prefix ns26: . dbr:Ebola owl:sameAs ns26:Sakit_na_Ebola , , . @prefix dbpedia-hr: . dbr:Ebola owl:sameAs dbpedia-hr:Ebola . @prefix dbpedia-als: . dbr:Ebola owl:sameAs dbpedia-als:Ebolafieber , , , wikidata:Q51993 , , . @prefix dbpedia-sv: . dbr:Ebola owl:sameAs dbpedia-sv:Ebola , , , . @prefix ns30: . dbr:Ebola owl:sameAs ns30:Maladi_viris_Ebola , . @prefix dbpedia-ms: . dbr:Ebola owl:sameAs dbpedia-ms:Penyakit_virus_Ebola . @prefix dbpedia-fi: . dbr:Ebola owl:sameAs dbpedia-fi:Ebola , , , , . @prefix dbpedia-it: . dbr:Ebola owl:sameAs dbpedia-it:Malattia_da_virus_Ebola . @prefix dbpedia-nn: . dbr:Ebola owl:sameAs dbpedia-nn:Ebola-virussjukdom . @prefix ns35: . dbr:Ebola owl:sameAs ns35:Five_Ebola . @prefix dbpedia-et: . dbr:Ebola owl:sameAs dbpedia-et:Ebola_viirushaigus , . @prefix dbpedia-la: . dbr:Ebola owl:sameAs dbpedia-la:Ebola_febris_haemorrhagica , , . @prefix dbpedia-war: . dbr:Ebola owl:sameAs dbpedia-war:Sakit_nga_Ebola . @prefix dbpedia-cs: . dbr:Ebola owl:sameAs dbpedia-cs:Ebola , . @prefix ns40: . dbr:Ebola owl:sameAs ns40:Ebola_virus_disease , , . @prefix ns41: . dbr:Ebola owl:sameAs ns41:Evola_virusmanta_unquyqa , . @prefix dbpedia-id: . dbr:Ebola owl:sameAs dbpedia-id:Penyakit_virus_Ebola , , , . @prefix ns43: . dbr:Ebola owl:sameAs ns43:Ebola . @prefix ns44: . dbr:Ebola owl:sameAs ns44:Ebola . @prefix dbt: . dbr:Ebola dbp:wikiPageUsesTemplate dbt:Use_dmy_dates , dbt:Short_description , dbt:Use_British_English , dbt:Anchor , dbt:Reflist , dbt:As_of , dbt:Refend , dbt:By_whom , dbt:Refbegin , dbt:Convert , dbt:Portal_bar , dbt:Pp-vandalism , dbt:Ebola , dbt:Authority_control , dbt:Infobox_medical_condition , dbt:For , dbt:Medcn , dbt:About , dbt:Subject_bar , dbt:Medical_condition_classification_and_resources , dbt:See_also , dbt:TOC_limit , dbt:Zoonotic_viral_diseases , dbt:Cite_book , dbt:Main , dbt:Cite_web ; dbo:thumbnail . @prefix ns46: . dbr:Ebola dbo:wikiPageInterLanguageLink ns46:Ebola_virus_disease ; dbp:diagnosis "Finding the virus, viral RNA, or antibodies in blood"@en ; dbp:diseasesdb 18043 . @prefix xsd: . dbr:Ebola dbp:icd "78.89"^^xsd:double , ""@en , "A98.4"@en ; dbp:meshid "D019142"@en ; dbp:onset "Two days to three weeks post exposure"@en ; dbp:symptoms "Fever, sore throat, muscular pain, headaches, diarrhoea, bleeding"@en ; dbp:treatment dbr:Supportive_care ; dbp:caption "Two nurses standing near Mayinga N'Seka, a nurse with Ebola virus disease in the 1976 outbreak in Zaire. N'Seka died a few days later."@en ; dbp:causes "Ebolaviruses spread by direct contact"@en ; dbp:commons "y"@en ; dbp:commonsSearch "Ebola"@en ; dbp:d "y"@en ; dbp:field ; dbp:imageSize 200 ; dbp:medlineplus 1339 ; dbp:n "y"@en ; dbp:nSearch "Category:Ebola virus"@en ; dbp:q "y"@en ; dbp:synonyms "Ebola haemorrhagic fever , Ebola virus disease"@en ; dbp:v "y"@en ; dbp:vSearch "Ebola"@en ; dbp:wikt "y"@en ; dbp:wiktSearch "Ebola"@en ; dbo:abstract "Gor\u0105czka krwotoczna Ebola, choroba wywo\u0142ana przez wirus Ebola, EHF (od ang. Ebola hemorrhagic fever), EVD (od ang. Ebola virus disease) \u2013 ci\u0119\u017Cka, cz\u0119sto \u015Bmiertelna choroba zaka\u017Ana wywo\u0142ana przez wirus Ebola. Zgodnie z Mi\u0119dzynarodow\u0105 Statystyczn\u0105 Klasyfikacj\u0105 Chor\u00F3b i Problem\u00F3w Zdrowotnych jest zaliczana do kategorii trzyznakowej A98: \u201EInne wirusowe gor\u0105czki krwotoczne niesklasyfikowane gdzie indziej\u201D. Objawy choroby pojawiaj\u0105 si\u0119 od dw\u00F3ch dni do trzech tygodni od zaka\u017Cenia wirusem, najcz\u0119\u015Bciej okres inkubacji choroby wynosi od 8 do 10 dni. Choroba zaczyna si\u0119 od gor\u0105czki (ponad 38,5 \u00B0C), b\u00F3lu g\u0142owy, mi\u0119\u015Bni i gard\u0142a oraz znacznego os\u0142abienia. W nast\u0119pnym etapie choroby wyst\u0119puj\u0105 wymioty, biegunka, wysypka, zaburzenia czynno\u015Bci nerek i w\u0105troby, a w cz\u0119\u015Bci przypadk\u00F3w krwawienia zar\u00F3wno wewn\u0119trzne, jak i zewn\u0119trzne. Epidemia choroby rozpoczyna si\u0119 od os\u00F3b, kt\u00F3re mia\u0142y kontakt z krwi\u0105 lub innymi p\u0142ynami ustrojowymi zaka\u017Conych zwierz\u0105t, takich jak ma\u0142py czy owoco\u017Cerne nietoperze. Uwa\u017Ca si\u0119, \u017Ce naturalnym rezerwuarem zarazk\u00F3w s\u0105 owoco\u017Cerne nietoperze, jednak pomimo intensywnych bada\u0144 nie zosta\u0142o to potwierdzone. Nast\u0119pnie wiriony mog\u0105 by\u0107 przenoszone pomi\u0119dzy lud\u017Ami poprzez bezpo\u015Bredni kontakt z krwi\u0105 i innymi p\u0142ynami ustrojowymi chorych oraz zmar\u0142ych na t\u0119 chorob\u0119 os\u00F3b, a tak\u017Ce poprzez bezpo\u015Bredni kontakt z przedmiotami ska\u017Conymi przez ich krew i inne p\u0142yny ustrojowe. Osoby, kt\u00F3re przeby\u0142y chorob\u0119, mog\u0105 przekazywa\u0107 wirusa poprzez niezabezpieczone kontakty seksualne przez 7 tygodni od wyzdrowienia. Zaliczana jest do wirusowych gor\u0105czek krwotocznych. Tym samym w Polsce, zgodnie z ustaw\u0105 z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu chor\u00F3b zaka\u017Anych u ludzi (Dz.U. z 2022 r. poz. 1657), osoby chore na gor\u0105czk\u0119 krwotoczn\u0105 Ebola podlegaj\u0105 obowi\u0105zkowej hospitalizacji, a osoby zdrowe, kt\u00F3re pozostawa\u0142y w styczno\u015Bci z chorymi na t\u0119 chorob\u0119, podlegaj\u0105 obowi\u0105zkowej kwarantannie lub nadzorowi epidemiologicznemu przez okres nie d\u0142u\u017Cszy ni\u017C 21 dni (art. 34 i 35 ustawy). Najwi\u0119ksz\u0105 do tej pory epidemi\u0105 tej choroby zar\u00F3wno pod wzgl\u0119dem liczby zachorowa\u0144, jak i liczby przypadk\u00F3w \u015Bmiertelnych, by\u0142a epidemia gor\u0105czki krwotocznej Ebola w Afryce Zachodniej."@pl , "Penyakit virus ebola (EVD) atau demam berdarah Ebola (EHF) adalah penyakit pada manusia yang disebabkan oleh virus Ebola. Masa inkubasi biasanya dimulai dua hari hingga tiga minggu setelah terjangkit virus, dengan adanya demam, sakit tenggorokan, nyeri otot, dan sakit kepala. Gejala ini biasanya diikuti dengan mual, muntah, dan diare, serta menurunnya fungsi liver dan ginjal. Pada kondisi tersebut, orang yang terpapar virus Ebola mulai mengalami masalah pendarahan."@in , "\u30A8\u30DC\u30E9\u51FA\u8840\u71B1\uFF08\u30A8\u30DC\u30E9\u3057\u3085\u3063\u3051\u3064\u306D\u3064\u3001Ebola hemorrhagic fever; EHF\uFF09\u3001\u307E\u305F\u306F\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u75C5\uFF08\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u3073\u3087\u3046\u3001Ebola virus disease; EVD\uFF09\u306F\u3001\u30D5\u30A3\u30ED\u30A6\u30A4\u30EB\u30B9\u79D1\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u5C5E\u306E\u30A6\u30A4\u30EB\u30B9\u3092\u75C5\u539F\u4F53\u3068\u3059\u308B\u6025\u6027\u30A6\u30A4\u30EB\u30B9\u6027\u611F\u67D3\u75C7\u3002\u30DE\u30FC\u30EB\u30D6\u30EB\u30B0\u75C5\u3001\u30E9\u30C3\u30B5\u71B1\u3001\u5357\u7C73\u51FA\u8840\u71B1\u3001\u30AF\u30EA\u30DF\u30A2\u30FB\u30B3\u30F3\u30B4\u51FA\u8840\u71B1\u3068\u4E26\u3076\u3001\u30A6\u30A4\u30EB\u30B9\u6027\u51FA\u8840\u71B1\u306E1\u3064\u3060\u304C\u3001\u611F\u67D3\u8005\u304C\u5FC5\u305A\u3057\u3082\u51FA\u8840\u75C7\u72B6\u3092\u5448\u3059\u308B\u308F\u3051\u3067\u306F\u306A\u3044\u305F\u3081\u3001\u56FD\u969B\u7684\u306B\u306F\u547C\u79F0\u304C\u30A8\u30DC\u30E9\u51FA\u8840\u71B1\u304B\u3089\u30A8\u30DC\u30E9\u30A6\u30A4\u30EB\u30B9\u75C5\u3078\u5207\u308A\u66FF\u308F\u308A\u3064\u3064\u3042\u308B\u3002\u4E3B\u306B\u30A2\u30D5\u30EA\u30AB\u3067\u767A\u751F\u3059\u308B\u3002 \u30D2\u30C8\u306B\u611F\u67D3\u3057\u3001\u6CBB\u7642\u958B\u59CB\u304C\u9045\u308C\u308B\u3068\u81F4\u6B7B\u7387\u306F80 - 90%\u306B\u4E0A\u308B\uFF08\u30A6\u30A4\u30EB\u30B9\u306B\u3088\u3063\u3066\u7570\u306A\u308B\uFF09\u3002\u307E\u305F\u3001\u4EEE\u306B\u6551\u547D\u3067\u304D\u305F\u3068\u3057\u3066\u3082\u91CD\u7BE4\u306A\u5F8C\u907A\u75C7\u3092\u6B8B\u3059\u3053\u3068\u304C\u3042\u308A\u3001\u30EA\u30B9\u30AF\u30B0\u30EB\u30FC\u30D7\u30EC\u30D9\u30EB4\u30A6\u30A4\u30EB\u30B9\u306E\u4E00\u3064\u3067\u3042\u308B\u3002\u4E00\u65B9\u3001\u6BD2\u6027\u3084\u81F4\u6B7B\u7387\u304C\u3042\u307E\u308A\u306B\u3082\u9AD8\u304F\u3001\u9060\u51FA\u3059\u308B\u6A5F\u4F1A\u3092\u5F97\u308B\u524D\u306B\u60A3\u8005\u304C\u6B7B\u4EA1\u3057\u3066\u3057\u307E\u3046\u3053\u3068\u304C\u5C02\u3089\u3067\u3042\u308B\u3053\u3068\u304B\u3089\u3001\u4E16\u754C\u7684\u6D41\u884C\u306B\u306F\u81F3\u3063\u3066\u3044\u306A\u3044\uFF08\u3053\u308C\u304C\u81F4\u6B7B\u7387\u304C\u6BD4\u8F03\u7684\u4F4E\u3044\u305F\u3081\u8EFD\u75C7\u306E\u60A3\u8005\u304C\u9060\u51FA\u3057\u3084\u3059\u304F\u4E16\u754C\u7684\u5927\u6D41\u884C\u3092\u5F15\u304D\u8D77\u3053\u3057\u305F\u65B0\u578B\u30A4\u30F3\u30D5\u30EB\u30A8\u30F3\u30B6\u3084\u65B0\u578B\u30B3\u30ED\u30CA\u30A6\u30A4\u30EB\u30B9\u611F\u67D3\u75C7\u3068\u306E\u9055\u3044\u3067\u3042\u308B\uFF09\u3002 2019\u5E747\u6708\u3001WHO\u306F\u30B3\u30F3\u30B4\u6C11\u4E3B\u5171\u548C\u56FD\u3067\u306E\u5927\u6D41\u884C\u306B\u3064\u3044\u3066\u300C\u56FD\u969B\u7684\u306B\u61F8\u5FF5\u3055\u308C\u308B\u516C\u8846\u885B\u751F\u4E0A\u306E\u7DCA\u6025\u4E8B\u614B(PHEIC)\u300D\u306B\u6307\u5B9A\u3057\u305F\u3002"@ja , "\u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola Virus Disease \u0627\u062E\u062A\u0635\u0627\u0631\u0627\u064B EVD)\u200F \u0623\u064A\u0636\u0627 \u0627\u0644\u062D\u0645\u0649 \u0627\u0644\u0646\u0632\u0641\u064A\u0629 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola Hemorrhagic Fever \u0627\u062E\u062A\u0635\u0627\u0631\u0627\u064B EHF)\u200F\u060C \u0623\u0648 \u0628\u0628\u0633\u0627\u0637\u0629 \u0625\u064A\u0628\u0648\u0644\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Ebola)\u200F\u060C \u0647\u0648 \u0645\u0631\u0636 \u064A\u0635\u064A\u0628 \u0627\u0644\u0628\u0634\u0631 \u0648\u063A\u064A\u0631\u0647\u0627 \u0645\u0646 \u0627\u0644\u0631\u0626\u064A\u0633\u064A\u0627\u062A \u0627\u0644\u0646\u0627\u062C\u0645\u0629 \u0639\u0646 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627 es. \u0627\u0644\u0639\u0644\u0627\u0645\u0627\u062A \u0648\u0627\u0644\u0623\u0639\u0631\u0627\u0636 \u062A\u0628\u062F\u0623 \u0639\u0627\u062F\u0629 \u0628\u064A\u0646 \u064A\u0648\u0645\u064A\u0646 \u0648\u062B\u0644\u0627\u062B\u0629 \u0623\u0633\u0627\u0628\u064A\u0639 \u0628\u0639\u062F \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0645\u0639 \u0627\u0644\u062D\u0645\u0649\u060C \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u062D\u0644\u0642\u060C \u0622\u0644\u0627\u0645 \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A\u060C \u0648\u0627\u0644\u0635\u062F\u0627\u0639. \u062B\u0645\u060C \u0642\u064A\u0621\u060C \u0625\u0633\u0647\u0627\u0644 \u0648\u0637\u0641\u062D \u0639\u0627\u062F\u0629 \u0645\u0627 \u062A\u062D\u062F\u062B\u060C \u062C\u0646\u0628\u0627 \u0625\u0644\u0649 \u062C\u0646\u0628 \u0645\u0639 \u0627\u0646\u062E\u0641\u0627\u0636 \u0648\u0638\u0627\u0626\u0641 \u0643\u0644\u0627 \u0645\u0646 \u0627\u0644\u0643\u0628\u062F \u0648\u0627\u0644\u0643\u0644\u0649. \u0641\u064A \u0647\u0630\u0627 \u0627\u0644\u0648\u0642\u062A \u064A\u0628\u062F\u0623 \u0628\u0639\u0636 \u0627\u0644\u0646\u0627\u0633 \u0628\u0627\u0644\u0646\u0632\u0641 \u062F\u0627\u062E\u0644\u064A\u0627 \u0648\u062E\u0627\u0631\u062C\u064A\u0627. \u0627\u0644\u0645\u0631\u0636 \u0630\u0648 \u0645\u062E\u0627\u0637\u0631 \u0639\u0627\u0644\u064A\u0629 \u0645\u0646 \u0627\u0644\u0645\u0648\u062A\u060C \u0645\u0645\u0627 \u0623\u0633\u0641\u0631 \u0639\u0646 \u0645\u0642\u062A\u0644 \u0645\u0627 \u0628\u064A\u0646 25 \u064890 \u0641\u064A \u0627\u0644\u0645\u0626\u0629 \u0645\u0646 \u0627\u0644\u0645\u0635\u0627\u0628\u064A\u0646 \u0641\u064A \u0627\u0644\u0645\u062A\u0648\u0633\u0637 \u0646\u062D\u0648 50 \u0641\u064A \u0627\u0644\u0645\u0626\u0629. \u0647\u0630\u0627 \u063A\u0627\u0644\u0628\u0627 \u0645\u0627 \u064A\u0631\u062C\u0639 \u0625\u0644\u0649 \u0627\u0646\u062E\u0641\u0627\u0636 \u0636\u063A\u0637 \u0627\u0644\u062F\u0645 \u0645\u0646 \u0641\u0642\u062F\u0627\u0646 \u0627\u0644\u0633\u0648\u0627\u0626\u0644\u060C \u0648\u0639\u0627\u062F\u0629 \u0645\u0627 \u064A\u0644\u064A \u0628\u0639\u062F 6-16 \u0623\u064A\u0627\u0645 \u0645\u0646 \u0638\u0647\u0648\u0631 \u0627\u0644\u0623\u0639\u0631\u0627\u0636. \u0648\u064A\u0646\u062A\u0634\u0631 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0627\u062A\u0635\u0627\u0644 \u0627\u0644\u0645\u0628\u0627\u0634\u0631 \u0645\u0639 \u0627\u0644\u0633\u0648\u0627\u0626\u0644 \u0641\u064A \u0627\u0644\u062C\u0633\u0645\u060C \u0645\u062B\u0644 \u0627\u0644\u062F\u0645\u060C \u0641\u064A \u0627\u0644\u0634\u062E\u0635 \u0627\u0644\u0645\u0635\u0627\u0628 \u0623\u0648 \u0627\u0644\u062D\u064A\u0648\u0627\u0646\u0627\u062A \u0627\u0644\u0623\u062E\u0631\u0649. \u0642\u062F \u064A\u062D\u062F\u062B \u0647\u0630\u0627 \u0623\u064A\u0636\u0627 \u0645\u0646 \u062E\u0644\u0627\u0644 \u0627\u0644\u0627\u062A\u0635\u0627\u0644 \u0645\u0639 \u0645\u0627\u062F\u0629 \u0645\u0644\u0648\u062B\u0629 \u0645\u0624\u062E\u0631\u0627 \u0645\u0639 \u0633\u0648\u0627\u0626\u0644 \u0627\u0644\u062C\u0633\u0645. \u0627\u0646\u062A\u0634\u0627\u0631 \u0627\u0644\u0645\u0631\u0636 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0647\u0648\u0627\u0621 \u0628\u064A\u0646 \u0627\u0644\u0631\u0626\u064A\u0633\u064A\u0627\u062A\u060C \u0628\u0645\u0627 \u0641\u064A \u0630\u0644\u0643 \u0627\u0644\u0628\u0634\u0631\u060C \u0644\u0645 \u064A\u062A\u0645 \u062A\u0648\u062B\u064A\u0642\u0647 \u0641\u064A \u0623\u064A \u0645\u062E\u062A\u0628\u0631 \u0623\u0648 \u062A\u062D\u062A \u0627\u0644\u0638\u0631\u0648\u0641 \u0627\u0644\u0637\u0628\u064A\u0639\u064A\u0629. \u0625\u0646 \u0627\u0644\u0645\u0646\u064A \u0623\u0648 \u062D\u0644\u064A\u0628 \u0627\u0644\u062B\u062F\u064A \u0644\u0634\u062E\u0635 \u0628\u0639\u062F \u0627\u0644\u0634\u0641\u0627\u0621 \u0645\u0646 \u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627 \u0642\u062F \u0644\u0627 \u064A\u0632\u0627\u0644 \u064A\u062D\u0645\u0644 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0644\u0639\u062F\u0629 \u0623\u0633\u0627\u0628\u064A\u0639 \u0623\u0648 \u0623\u0634\u0647\u0631. \u064A\u0639\u062A\u0642\u062F \u0623\u0646 \u062E\u0641\u0627\u0641\u064A\u0634 \u0627\u0644\u0641\u0627\u0643\u0647\u0629 \u0623\u0646 \u062A\u0643\u0648\u0646 \u0647\u064A \u0627\u0644\u0645\u0636\u064A\u0641 \u0627\u0644\u0637\u0628\u064A\u0639\u064A \u0644\u0644\u0645\u0631\u0636\u060C \u0648\u0647\u064A \u0642\u0627\u062F\u0631\u0629 \u0639\u0644\u0649 \u0646\u0642\u0644 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u062F\u0648\u0646 \u0623\u0646 \u062A\u062A\u0623\u062B\u0631 \u0628\u0647. \u0623\u0645\u0631\u0627\u0636 \u0623\u062E\u0631\u0649 \u0645\u062B\u0644 \u0627\u0644\u0645\u0644\u0627\u0631\u064A\u0627\u060C \u0627\u0644\u0643\u0648\u0644\u064A\u0631\u0627\u060C \u062D\u0645\u0649 \u0627\u0644\u062A\u064A\u0641\u0648\u0626\u064A\u062F\u060C \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u0633\u062D\u0627\u064A\u0627 \u0648\u063A\u064A\u0631\u0647\u0627 \u0627\u0644\u062D\u0645\u0649 \u0627\u0644\u0646\u0632\u0641\u064A\u0629 \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u0629 \u0642\u062F \u064A\u0634\u0628\u0647 \u0645\u0631\u0636 \u0641\u064A\u0631\u0648\u0633 \u0625\u064A\u0628\u0648\u0644\u0627. \u064A\u062A\u0645 \u0627\u062E\u062A\u0628\u0627\u0631 \u0639\u064A\u0646\u0627\u062A \u0645\u0646 \u0627\u0644\u062F\u0645 \u0644\u0644\u062D\u0645\u0636 \u0646\u0648\u0648\u064A \u0631\u064A\u0628\u0648\u0632\u064A \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u060C \u0627\u0644\u0623\u062C\u0633\u0627\u0645 \u0627\u0644\u0645\u0636\u0627\u062F\u0629 \u0627\u0644\u0641\u064A\u0631\u0648\u0633\u064A\u0629 \u0623\u0648 \u0627\u0644\u0641\u064A\u0631\u0648\u0633 \u0646\u0641\u0633\u0647 \u0644\u0644\u062A\u0623\u0643\u062F \u0645\u0646 \u0627\u0644\u062A\u0634\u062E\u064A\u0635."@ar , "Ebola of ebola hemorragische koorts is een bij mensen voorkomende virusziekte die wordt veroorzaakt door het ebolavirus. De ziekte is zeldzaam en komt voor in de vorm van regionale uitbraken in landen in Midden-Afrika. De naam ebola komt van de gelijknamige rivier in Congo-Kinshasa (destijds Za\u00EFre) waar in 1976 een tweede uitbraak plaatsvond en ebola voor het eerst door Guido van der Groen en Peter Piot werd herkend en aangetoond in de plaats Yambuku, gelegen op 95 kilometer van de rivier de Ebola. De aandoening veroorzaakt een hoog sterftecijfer en er is nog geen specifieke behandeling of geneesmiddel beschikbaar tegen het virus."@nl , "La malattia da virus Ebola (in inglese Ebolavirus disease - EVD), precedentemente conosciuta come febbre emorragica Ebola (Ebola haemorrhagic fever - EHF) \u00E8 una febbre emorragica degli esseri umani e di altri primati causata dal virus Ebola; \u00E8 stata identificata per la prima volta in Sudan e nella Repubblica Democratica del Congo. La malattia si verifica in genere in focolai epidemici che interessano regioni tropicali dell'Africa sub-sahariana. A causa della carenza di strumentario appropriato e di protocolli igienico-sanitari, le epidemie su vasta scala scoppiano con pi\u00F9 facilit\u00E0 nelle aree pi\u00F9 povere ed isolate prive di ospedali moderni e di personale addestrato. Il virus pu\u00F2 essere acquisito entrando a contatto con sangue o fluidi corporei di un animale infetto, comunemente le scimmie o i pipistrelli della frutta. Ad oggi non pare possibile che possa esistere un contagio tra animali e uomo attraverso l'aria, in ambiente naturale. Le volpi volanti sono ritenute in grado di trasportare e diffondere il virus senza esserne colpite, ovvero senza sviluppare la malattia. I sintomi della malattia iniziano da due giorni a tre settimane dopo aver contratto il virus, con febbre, faringodinia (mal di gola), dolori muscolari, cefalea (mal di testa) e orecchie tappate. A questi primi sintomi fanno in genere seguito nausea, vomito, e diarrea, unitamente a segni di alterazione della funzionalit\u00E0 epatica e renale. In questa fase della malattia alcune persone possono cominciare a presentare emorragie che si possono manifestare verso l'esterno (emorragie esterne) oppure interessare alcune cavit\u00E0 corporee (emorragie interne). Il rischio di morte tra le persone infette \u00E8 estremamente alto (50-70%). Una volta che si sia verificata l'infezione umana, la malattia pu\u00F2 diffondersi attraverso gli esseri umani. Coloro che sopravvivono alla malattia possono essere in grado di trasmettere il virus attraverso lo sperma per quasi due mesi. La diagnosi richiede l'esclusione di altre malattie caratterizzate da sintomi simili, come la malaria, il colera, e altre febbri emorragiche virali. Per confermare la diagnosi, i campioni di sangue del caso sospetto vengono testati con la ricerca di anticorpi anti-virus, RNA virale, o del virus stesso. Non esiste una terapia specifica per la malattia. Il trattamento dei pazienti affetti \u00E8 sostanzialmente un trattamento di supporto che comprende un'adeguata reidratazione orale (semplice acqua leggermente zuccherata e addizionata di una modica quantit\u00E0 di sale) o l'infusione di fluidi per via endovenosa."@it , "La enfermedad por el virus del \u00C9bola (EVE), enfermedad del \u00E9bolavirus, fiebre hemorr\u00E1gica del \u00C9bola (FHE), enfermedad del \u00C9bola\u200B o, simplemente, como \u00E9bola,\u200B es una enfermedad causada en el ser humano por el virus del \u00C9bola. Normalmente los s\u00EDntomas comienzan entre los dos d\u00EDas y las tres semanas despu\u00E9s de haber contra\u00EDdo el virus, con fiebre, dolor de garganta, dolores musculares, y dolor de cabeza. Por lo general, siguen n\u00E1useas, v\u00F3mitos y diarrea, junto con fallo hep\u00E1tico y renal. En ese momento, algunos pacientes empiezan a sufrir complicaciones hemorr\u00E1gicas.\u200B El virus puede contraerse por contacto con la sangre o los fluidos corporales de animales infectados (generalmente monos o murci\u00E9lagos de la fruta).\u200B No se ha documentado la transmisi\u00F3n a\u00E9rea en el entorno natural.\u200BSe cree que los murci\u00E9lagos de la fruta son portadores del virus y pueden contagiarlo sin resultar afectados. Una vez que un ser humano resulta infectado, la enfermedad tambi\u00E9n puede contagiarse entre personas. Los supervivientes de sexo masculino pueden transmitir la enfermedad a trav\u00E9s del semen hasta por a\u00F1o y medio. Con el fin de establecer un diagn\u00F3stico, por lo general se descartan antes otras enfermedades con s\u00EDntomas parecidos, como la malaria, el c\u00F3lera y otras fiebres hemorr\u00E1gicas virales. Con el fin de confirmar dicho diagn\u00F3stico se hacen pruebas de sangre para detectar anticuerpos, ARNviral o el propio virus.\u200B La enfermedad es causada por cualquiera de las cinco especies de virus \u00E9bola que han sido identificadas como: Bundibugyo ebolavirus (BDBV), Reston ebolavirus (RESTV), Sudan ebolavirus (SUDV), Ta\u00EF Forest ebolavirus (TAFV) y Zaire ebolavirus (ZEBOV).\u200B La prevenci\u00F3n incluye la reducci\u00F3n del contagio de la infecci\u00F3n de monos o cerdos al hombre. Una forma de llevarlo a cabo ser\u00EDa la verificaci\u00F3n de la infecci\u00F3n en dichos animales y su matanza y posterior eliminaci\u00F3n de los cuerpos en caso de detecci\u00F3n de la enfermedad. Tambi\u00E9n ser\u00EDa de ayuda una adecuada cocci\u00F3n de la carne, as\u00ED como llevar ropa protectora durante su manipulaci\u00F3n, como llevarla tambi\u00E9n y lavarse las manos siempre que se est\u00E9 cerca de alguien infectado. Las muestras de tejidos o fluidos corporales de pacientes infectados deben manipularse con especial precauci\u00F3n.\u200B No se dispone de un tratamiento m\u00E9dico espec\u00EDfico; los esfuerzos realizados para ayudar a los pacientes infectados consisten en administrarles bien sales de rehidrataci\u00F3n oral (agua con az\u00FAcar y sal) o fluidos intravenosos.\u200BEn el a\u00F1o 2015 comenz\u00F3 la fase de pruebas de una vacuna, comprob\u00E1ndose en los ensayos preliminares una efectividad del 100%.\u200B La tasa de mortalidad de la enfermedad es elevada: con una frecuencia de fallecimientos de entre el 50% y el 90% de los infectados por el virus.\u200B\u200B La infecci\u00F3n por el virus del \u00E9bola fue identificada por primera vez en Sud\u00E1n y la Rep\u00FAblica Democr\u00E1tica del Congo. La enfermedad aparece normalmente en brotes en las regiones tropicales del \u00C1frica subsahariana.\u200BEntre 1976 (a\u00F1o en el que se detect\u00F3 el virus por primera vez) y 2013, la Organizaci\u00F3n Mundial de la Salud report\u00F3 1.716 casos.\u200B\u200BEs decir, resultaron infectadas menos de 1000 personas por a\u00F1o.\u200B\u200BHasta 2014 los brotes de \u00E9bola solo hab\u00EDan afectado a regiones concretas de \u00C1frica. A partir de la epidemia de 2014 originada en \u00C1frica Occidental, se han producido contagios en otros continentes. El brote de 2014-2015 fue el m\u00E1s virulento, y afect\u00F3 a Guinea, Sierra Leona, Liberia y Nigeria.\u200B\u200B\u200B"@es , "\u4F0A\u6CE2\u62C9\u51FA\u8840\u71B1\uFF08\u53C8\u540D\uFF1A\u4F0A\u6CE2\u62C9\u75C5\u6BD2\u75C5\uFF1B\u901A\u7A31\uFF1A\u4F0A\u6CE2\u62C9\uFF1B\u82F1\u8BED\uFF1AEbola Hemorrhagic Fever\uFF09\u662F\u4E00\u7A2E\u7531\u4F0A\u6CE2\u62C9\u75C5\u6BD2\u5F15\u8D77\uFF0C\u591A\u51FA\u73FE\u65BC\u9748\u9577\u52D5\u7269\u8EAB\u4E0A\u7684\u4EBA\u755C\u5171\u60A3\u50B3\u67D3\u75C5\uFF0C\u56E0\u5728\u57C3\u535A\u62C9\u6CB3\u9644\u8FD1\u53D1\u73B0\uFF0C\u56E0\u6B64\u5F97\u540D\u3002\u7F79\u60A3\u6B64\u75C5\u7684\u4EBA\u6703\u57282\u5929\u81F33\u9031\u5167\u9678\u7E8C\u51FA\u73FE\u767C\u71D2\u3001\u982D\u75DB\u3001\u808C\u8089\u75BC\u75DB\u3001\u5614\u5410\u3001\u8179\u7009\u4EE5\u53CA\u51FA\u75B9\u7B49\u75C7\u72C0\u3002\u75C5\u60C5\u4E4B\u540E\u6703\u9032\u4E00\u6B65\u60E1\u5316\u70BA\u809D\u8870\u7AED\u3001\u814E\u8870\u7AED\uFF0C\u6B65\u5165\u6B64\u968E\u6BB5\uFF0C\u75C5\u4EBA\u6216\u6703\u51FA\u73FE\u9AD4\u5167\u3001\u4F53\u5916\u51FA\u8840\u73FE\u8C61\uFF0C\u4E26\u53EF\u80FD\u5728\u9996\u500B\u75C7\u72C0\u51FA\u73FE\u5F8C\u76846\u81F316\u5929\u5185\u56E0\u8840\u5BB9\u91CF\u904E\u4F4E\u6216\u591A\u91CD\u5668\u5B98\u8870\u7AED\u800C\u6B7B\u4EA1\u3002 \u4F0A\u6CE2\u62C9\u60A3\u8005\u591A\u56E0\u63A5\u89F8\u4E86\u5E36\u6709\u75C5\u6BD2\u7684\u9AD4\u6DB2\uFF08\u5305\u62EC\u8840\u6DB2\uFF09\u3001\u5668\u5B98\uFF0C\u6216\u9593\u63A5\u89F8\u6478\u5230\u6700\u8FD1\u53D7\u6C61\u67D3\u4E4B\u5668\u5177\u800C\u67D3\u75C5\u3002\u76EE\u524D\u5C1A\u672A\u6709\u8DB3\u5920\u7684\u8B49\u64DA\u986F\u793A\u75C5\u6BD2\u80FD\u7D93\u7A7A\u6C23\u5FAE\u7C92\u5728\u9748\u9577\u52D5\u7269\u9593\u50B3\u64AD\u3002\u60A3\u8005\u7684\u7CBE\u6DB2\u6216\u6BCD\u4E73\u5728\u5176\u5EB7\u5FA9\u5F8C\u7684\u6578\u9031\u81F3\u6578\u6708\u5185\uFF0C\u4ECD\u53EF\u80FD\u8F09\u6709\u75C5\u6BD2\u3002\u679C\u8760\u88AB\u8A8D\u70BA\u662F\u57C3\u535A\u62C9\u75C5\u539F\u9AD4\u7684\u5929\u7136\u5BBF\u4E3B\uFF0C\u80FD\u5728\u81EA\u8EAB\u4E0D\u53D7\u5F71\u97FF\u7684\u72C0\u6CC1\u4E0B\u5C07\u4E4B\u6563\u64AD\u3002\u75AB\u75C7\u7684\u63A7\u5236\u5728\u4E8E\u91AB\u7642\u754C\u4EE5\u53CA\u4E00\u5B9A\u7A0B\u5EA6\u7684\u793E\u5340\u914D\u5408\u3002\u524D\u7DDA\u91AB\u5B78\u63AA\u65BD\u5305\u62EC\uFF1A\u5FEB\u901F\u7684\u75C5\u4F8B\u5075\u6E2C\u3001\u5BE6\u9A57\u5BA4\u8A3A\u65B7\u3001\u63A5\u89F8\u8005\u8FFD\u8E64\u3001\u6B63\u78BA\u770B\u8B77\u3001\u8B39\u614E\u8655\u7406\u91AB\u7642\u5EE2\u7269\uFF0C\u4EE5\u53CA\u59A5\u5584\u5B89\u846C\u6216\u706B\u5316\u5C4D\u9AD4\u3002\u6E1B\u5C11\u63A5\u89F8\u53D7\u611F\u67D3\u7684\u500B\u9AD4\u70BA\u793E\u5340\u9632\u75AB\u7684\u4E00\u5927\u91CD\u9EDE\u3002\u5728\u8FD1\u8DDD\u96E2\u63A5\u89F8\u60A3\u8005\u6642\uFF0C\u5E94\u7A7F\u8457\u5B8C\u6574\u7684\u9023\u8EAB\u578B\u9632\u8B77\u8863\u7269\uFF0C\u4E26\u52E4\u52A0\u6D17\u624B\u3002\u53E2\u6797\u8089\u6613\u6CBE\u67D3\u75C5\u6BD2\uFF0C\u6545\u5728\u5FB9\u5E95\u716E\u719F\u5F8C\u65B9\u80FD\u9032\u98DF\uFF1B\u5728\u8655\u7406\u9019\u985E\u7522\u7269\u6642\uFF0C\u4E5F\u9700\u4F69\u6234\u91AB\u7528\u624B\u5957\u3002 \u76E1\u53EF\u80FD\u6487\u9664\u8AF8\u5982\u7627\u75BE\u3001\u970D\u4E82\u3001\u8166\u819C\u708E\u3001\u5176\u4ED6\u75C5\u6BD2\u6027\u51FA\u8840\u71B1\u7B49\u53EF\u9020\u6210\u8FD1\u4F3C\u75C7\u72C0\u7684\u75BE\u75C5\u70BA\u8A3A\u65B7\u4F0A\u6CE2\u62C9\u51FA\u8840\u71B1\u7684\u9996\u8981\u5DE5\u4F5C\u3002\u8840\u6DB2\u6A23\u672C\u4E2D\u4E4B\u6297\u75C5\u6BD2\u9AD4\u3001\u75C5\u6BD2\u7684\u6838\u7CD6\u6838\u9178\u6216\u75C5\u6BD2\u672C\u8EAB\u5747\u70BA\u9451\u5B9A\u7684\u6307\u6A19\u3002\u76EE\u524D\u5C1A\u672A\u6709\u91DD\u5C0D\u6027\u7684\u6CBB\u7642\u65B9\u6848\uFF0C\u75AB\u82D7\u53CA\u85E5\u7269\u5C1A\u5F85\u7814\u767C\u3002\u75C5\u4EBA\u5927\u591A\u63A5\u53D7\u6216\u975C\u8108\u6CE8\u5C04\u7B49\uFF0C\u4F46\u9019\u53EA\u662F\u63D0\u9AD8\u5B58\u6D3B\u7387\u7684\u8212\u7DE9\u6027\u7642\u6CD5\uFF0C\u4EE5\u964D\u4F4E\u75BE\u75C5\u6240\u5E36\u4F86\u7684\u50B7\u5BB3\u53CA\u4F75\u767C\u75C7\u7684\u98A8\u96AA\u3002\u6DF1\u5207\u6CBB\u7642\u5247\u80FD\u9032\u4E00\u6B65\u5E94\u5BF9\u5668\u5B98\u8870\u7AED\u554F\u984C\u3002\u6839\u64DA\u8FC7\u5F80\u75AB\u60C5\uFF0C\u8BE5\u51FA\u8840\u71B1\u53EF\u9020\u6210\u9AD8\u905425-90%\uFF08\u5E73\u5747\u7D04\u4E94\u6210\uFF09\u7684\u7D9C\u5408\u81E8\u5E8A\u81F4\u6B7B\u7387\u3002 \u8BE5\u75C5\u57281976\u5E74\u9996\u6B21\u51FA\u73FE\u65BC\u7576\u6642\u7684\u8607\u4E39\u53CA\u85A9\u4F0A\uFF0C\u4E26\u5E38\u65BC\u975E\u6D32\u6492\u54C8\u62C9\u4EE5\u5357\u7684\u5730\u5340\u9020\u6210\u9593\u6B47\u6027\u7206\u767C\u3002\u76F4\u81F32013\u5E74\uFF0C\u4E16\u754C\u885B\u751F\u7D44\u7E54\u5171\u516C\u4F48\u4E862,387\u5B97\u78BA\u8A3A\u500B\u6848\uFF0C\u5408\u8A0824\u6B21\u7206\u767C\uFF0C\u7E3D\u6B7B\u4EA1\u4EBA\u6578\u70BA1,590\u540D\u3002\u6700\u56B4\u91CD\u7684\u4E00\u6B21\u6D41\u884C\uFF0C\u70BA\u8086\u8650\u897F\u975E\u76842013-16\u5E74\u75AB\u75C7\uFF1B\u8FD9\u6B21\u7206\u767C\u6700\u7D42\u611F\u67D3\u4E8628,637\u4EBA\uFF0C\u596A\u53D6\u4E8611,315\u4EBA\u7684\u6027\u547D\u3002"@zh , "Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after becoming infected with the virus. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash and decreased liver and kidney function, at which point, some people begin to bleed both internally and externally. The disease kills between 25% and 90% of those infected \u2013 about 50% on average. Death is often due to shock from fluid loss, and typically occurs between six and 16 days after the first symptoms appear. Early treatment of symptoms increases the survival rate considerably compared to late start. The virus spreads through direct contact with body fluids, such as blood from infected humans or other animals, or from contact with items that have recently been contaminated with infected body fluids. There have been no documented cases, either in nature or under laboratory conditions, of the disease spreading through the air between humans or other primates. After a person recovers from Ebola, their semen or breast milk may continue to carry the virus for anywhere between several weeks to several months. Fruit bats are believed to be the normal carrier in nature; they are able to spread the virus without being affected by it. The symptoms of Ebola may resemble those of several other diseases, including malaria, cholera, typhoid fever, meningitis and other viral hemorrhagic fevers. Diagnosis is confirmed by testing blood samples for the presence of viral RNA, viral antibodies or the virus itself. Control of outbreaks requires coordinated medical services and community engagement, including rapid detection, contact tracing of those exposed, quick access to laboratory services, care for those infected, and proper disposal of the dead through cremation or burial. Samples of body fluids and tissues from people with the disease should be handled with extreme caution. Prevention measures include wearing proper protective clothing and washing hands when around a person with the disease, and limiting the spread of the disease from infected animals to humans \u2013 by wearing protective clothing while handling potentially infected bushmeat, and by cooking bushmeat thoroughly before eating it. An Ebola vaccine was approved in the United States in December 2019. While there is no approved treatment for Ebola as of 2019, two treatments (atoltivimab/maftivimab/odesivimab and ansuvimab) are associated with improved outcomes. Supportive efforts also improve outcomes. These include oral rehydration therapy (drinking slightly sweetened and salty water) or giving intravenous fluids, and treating symptoms. In October 2020, Atoltivimab/maftivimab/odesivimab (Inmazeb) was approved for medical use in the United States to treat the disease caused by Zaire ebolavirus. The disease was first identified in 1976, in two simultaneous outbreaks: one in Nzara (a town in South Sudan) and the other in Yambuku (the Democratic Republic of the Congo), a village near the Ebola River, from which the disease takes its name. Ebola outbreaks occur intermittently in tropical regions of sub-Saharan Africa. Between 1976 and 2012, according to the World Health Organization, there were 24 outbreaks of Ebola resulting in a total of 2,387 cases, and 1,590 deaths. The largest Ebola outbreak to date was an epidemic in West Africa from December 2013 to January 2016, with 28,646 cases and 11,323 deaths. On 29 March 2016, it was declared to no longer be an emergency. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017, and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency."@en , "Ebola gaixotasun birikoa edo ebola sukar hemorragikoa jatorri birikoko gaixotasun kutsakorra da, ebola birusak sortua, gizakiari eta beste primate batzuei eragiten diena. Gizakiarengan gaitza nahiko berria da, lehen kasuak Kongoko Errepublika Demokratikoan eta Sudanen 1976an agertu baitziren. Gaitzaren heriotza-tasa altua da, infektatuen % 50 eta % 90 artean hiltzen baita, birus motaren arabera. 1976az geroztik, birus eragileak epidemia batzuk sortu ditu Afrika aldean. Izurrite gehienak Kongoko Errepublika Demokratikoan, Gabonen, Sudanen, Ugandan eta Boli Kostan gertatu dira. Horretaz gain, birusak Afrikako erreserbetan bizi diren gorila eta txinpantzeen artean hondamen handiak egin ditu, milaka primate akabatu baititu urte gutxitan."@eu , "( \uC5D0\uBCFC\uB77C\uB294 \uC5EC\uAE30\uB85C \uC5F0\uACB0\uB429\uB2C8\uB2E4. \uB2E4\uB978 \uB73B\uC5D0 \uB300\uD574\uC11C\uB294 \uC5D0\uBCFC\uB77C (\uB3D9\uC74C\uC774\uC758) \uBB38\uC11C\uB97C \uCC38\uACE0\uD558\uC2ED\uC2DC\uC624.) \uC5D0\uBCFC\uB77C \uCD9C\uD608\uC5F4(Ebola hemorrhagic fever; EHF) \uB610\uB294 \uC5D0\uBCFC\uB77C\uBC14\uC774\uB7EC\uC2A4\uBCD1(Ebola virus disease; EVD)\uB294 \uBC14\uC774\uB7EC\uC2A4\uC131 \uCD9C\uD608\uC5F4 \uC911 \uD558\uB098\uC774\uBA70, \uC5D0\uBCFC\uB77C \uBC14\uC774\uB7EC\uC2A4\uB85C \uC778\uD574 \uC77C\uC5B4\uB098\uB294 \uC778\uAC04\uC758 \uC9C8\uBCD1\uC774\uB2E4. \uC99D\uC0C1\uC758 \uC7A0\uBCF5\uAE30\uB294 \uBC14\uC774\uB7EC\uC2A4 \uAC10\uC5FC \uC774\uD6C4 \uC774\uD2C0\uBD80\uD130 \uC0BC\uC8FC\uAE4C\uC9C0 \uC9C0\uC18D\uB418\uBA70 \uBC1C\uC5F4, \uBAA9\uACFC \uADFC\uC721\uC758 \uD1B5\uC99D, \uB450\uD1B5\uC744 \uB3D9\uBC18\uD55C\uB2E4. \uC774\uD6C4 \uD1B5\uC0C1\uC801\uC73C\uB85C \uAD6C\uC5ED\uC9C8, \uAD6C\uD1A0, \uC124\uC0AC\uC640 \uD568\uAED8 \uAC04\uACFC \uCF69\uD325 \uAE30\uB2A5\uC758 \uC545\uD654 \uC99D\uC0C1\uC774 \uB098\uD0C0\uB09C\uB2E4. \uC774 \uC2DC\uC810\uC5D0\uC11C \uBA87\uBA87 \uC0AC\uB78C\uB4E4\uC740 \uCD9C\uD608 \uC99D\uC0C1\uC774 \uB098\uD0C0\uB098\uAE30\uB3C4 \uD55C\uB2E4. \uCCB4\uC561\uC73C\uB85C \uAC10\uC5FC\uB418\uB294 \uAC10\uC5FC\uBCD1 \uC911\uC5D0\uC11C\uB294 \uC804\uC5FC\uB825\uC774 \uB9E4\uC6B0 \uAC15\uD55C \uC9C8\uBCD1\uC774\uBA70 \uCE58\uC0AC\uC728\uB3C4 \uB192\uB2E4. \uC5D0\uBCFC\uB77C \uD658\uC790 \uCE58\uB8CC\uACBD\uD5D8\uC774 \uAC00\uC7A5 \uB9CE\uC740 \uC758\uC0AC\uC778 \uC170\uC774\uD06C \uC6B0\uB9C8\uB974 \uCE78 \uBC15\uC0AC\uB97C \uBE44\uB86F\uD558\uC5EC \uC804 \uC138\uACC4\uC5D0\uC11C \uC758\uB8CC\uC778 184\uBA85\uC774 \uAC10\uC5FC\uB410\uACE0 \uADF8 \uC911 \uC808\uBC18\uC774 \uC0AC\uB9DD\uD588\uB2E4.\uC138\uACC4\uBCF4\uAC74\uAE30\uAD6C\uC5D0\uC11C\uB294 \uC5D0\uBCFC\uB77C\uAC00 \uACF5\uAE30\uB85C \uC804\uC5FC\uB418\uC9C0 \uC54A\uC73C\uBA70 \uCCB4\uC561\uC73C\uB85C\uB9CC \uC804\uC5FC\uB41C\uB2E4\uACE0 \uBC1C\uD45C\uD588\uC9C0\uB9CC, \uACF5\uAE30 \uC804\uC5FC\uC758 \uAC00\uB2A5\uC131\uC774 \uC788\uB2E4\uB294 \uC804\uBB38\uAC00\uB4E4\uC758 \uC758\uACAC\uC774 \uC788\uB2E4. \uAC10\uC5FC\uC790\uB85C\uBD80\uD130 1m \uC774\uC0C1 \uB5A8\uC5B4\uC9C0\uBA74 \uC0C1\uB300\uC801\uC73C\uB85C \uC548\uC804\uD55C \uAC83\uC73C\uB85C \uC54C\uB824\uC838 \uC788\uB2E4. \uC5D0\uBCFC\uB77C \uCD9C\uD608\uC5F4\uC758 \uCD5C\uCD08 \uAC10\uC5FC\uC740, \uAC10\uC5FC\uB41C \uC6D0\uC22D\uC774\uB098 \uACFC\uC77C\uBC15\uC950\uC758 \uD53C\uB098 \uCCB4\uC561\uC5D0 \uC811\uCD09\uD558\uC5EC \uC62E\uB294 \uAC83\uC73C\uB85C \uCD94\uC815\uB41C\uB2E4. \uACFC\uC77C\uBC15\uC950\uB294 \uBC14\uC774\uB7EC\uC2A4\uC758 \uB9E4\uAC1C\uCCB4\uC774\uBA74\uC11C \uC99D\uC0C1\uC774 \uB098\uD0C0\uB098\uC9C0 \uC54A\uC740 \uCC44 \uC804\uD30C\uC2DC\uD0AC \uC218 \uC788\uB294 \uAC83\uC73C\uB85C \uC0DD\uAC01\uB41C\uB2E4. \uC778\uAC04\uC5D0\uAC8C \uC5D0\uBCFC\uB77C \uBC14\uC774\uB7EC\uC2A4\uAC00 \uAC10\uC5FC\uB418\uBA74, \uC774\uD6C4 \uC0AC\uB78C \uB300 \uC0AC\uB78C \uAC10\uC5FC\uC774 \uAC00\uB2A5\uD558\uB2E4. \uB0A8\uC131 \uC0DD\uC874\uC790\uB294 \uC57D 2\uAC1C\uC6D4 \uB3D9\uC548 \uC815\uC561\uC744 \uD1B5\uD574 \uC9C8\uBCD1\uC744 \uC62E\uAE38 \uC218 \uC788\uB2E4. \uC9C4\uB2E8\uC744 \uC704\uD574, \uC77C\uBC18\uC801\uC73C\uB85C \uCF5C\uB808\uB77C\uB098 \uB9D0\uB77C\uB9AC\uC544 \uAC19\uC740 \uBE44\uC2B7\uD55C \uC99D\uC0C1\uC744 \uBCF4\uC774\uB294 \uB2E4\uB978 \uBC14\uC774\uB7EC\uC2A4\uC131 \uCD9C\uD608\uC5F4 \uC9C8\uBCD1\uC744 \uC81C\uC678\uD558\uACE0 \uD655\uC778\uD55C\uB2E4. \uD608\uC561 \uAC80\uC0AC\uB97C \uD1B5\uD574 \uBC14\uC774\uB7EC\uC2A4\uC758 \uD56D\uCCB4, \uBC14\uC774\uB7EC\uC2A4\uC131 RNA, \uBC14\uC774\uB7EC\uC2A4 \uADF8 \uC790\uCCB4\uAC00 \uC874\uC7AC\uD568\uC744 \uD655\uC778\uD558\uC5EC \uC9C4\uB2E8\uC744 \uD655\uC778\uD55C\uB2E4. \uC608\uBC29\uBC95\uC73C\uB85C\uB294 \uAC10\uC5FC\uB41C \uB3FC\uC9C0 \uBC0F \uC6D0\uC22D\uC774 \uC0AC\uC774\uC5D0\uC11C \uC9C8\uBCD1 \uD655\uC0B0\uC744 \uB9C9\uB294 \uAC83\uB3C4 \uD3EC\uD568\uD55C\uB2E4. \uAC10\uC5FC\uB41C \uB3D9\uBB3C\uC758 \uBC14\uC774\uB7EC\uC2A4 \uC720\uD615\uC744 \uD655\uC778\uD55C \uC774\uD6C4, \uC9C8\uBCD1\uC774 \uBC1C\uACAC\uB418\uACE0 \uC0AC\uB9DD\uD55C \uACBD\uC6B0 \uC989\uC2DC \uC0AC\uCCB4\uB97C \uD3D0\uAE30\uD55C\uB2E4. \uBCF4\uD638\uBCF5\uC744 \uCC29\uC6A9\uD55C \uCC44\uB85C \uC801\uC808\uD558\uAC8C \uACE0\uAE30\uB97C \uCDE8\uAE09\uD558\uACE0 \uC694\uB9AC\uD558\uB294 \uAC83\uB3C4 \uD6A8\uACFC\uC801\uC774\uBA70, \uAC10\uC5FC\uB41C \uD658\uC790 \uC8FC\uBCC0\uC5D0 \uB2E4\uAC00\uAC08 \uB54C\uB294 \uBCF4\uD638\uBCF5\uC744 \uC785\uACE0 \uC190\uC18C\uB3C5\uC744 \uCCA0\uC800\uD788 \uD574\uC57C \uD55C\uB2E4. \uC774 \uC9C8\uBCD1\uC744 \uAC00\uC9C4 \uC0AC\uB78C\uC5D0\uAC8C\uC11C \uB098\uC628 \uCCB4\uC561 \uBC0F \uC870\uC9C1 \uC0D8\uD50C\uC740 \uB9E4\uC6B0 \uC870\uC2EC\uD788 \uCDE8\uAE09\uB418\uC5B4\uC57C \uD55C\uB2E4. \uBC14\uC774\uB7EC\uC2A4\uB97C \uCE58\uB8CC\uD558\uB294 \uD2B9\uBCC4\uD55C \uBC29\uBC95\uC740 \uC5C6\uB2E4. \uAC10\uC5FC\uB41C \uD658\uC790\uC5D0\uAC8C \uBC0F \uB97C \uD1B5\uD574 \uD658\uC790\uAC00 \uC790\uC5F0\uC801\uC73C\uB85C \uD68C\uBCF5\uB418\uB294 \uAC83\uC744 \uB3D5\uB294\uB2E4. \uC774 \uC9C8\uBCD1\uC758 \uC0AC\uB9DD\uB960\uC740 50%\uC5D0\uC11C 90%\uB85C \uB9E4\uC6B0 \uB192\uB2E4. \uC774 \uC9C8\uBCD1\uC740 \uC81C\uC77C \uBA3C\uC800 \uCF69\uACE0 \uBBFC\uC8FC \uACF5\uD654\uAD6D\uACFC \uC218\uB2E8\uC5D0\uC11C \uD655\uC778\uB418\uC5C8\uB2E4. \uB610\uD55C, \uC77C\uBC18\uC801\uC73C\uB85C \uC0AC\uD558\uB77C \uC774\uB0A8 \uC544\uD504\uB9AC\uCE74\uC758 \uC5F4\uB300 \uC9C0\uC5ED\uC5D0\uC11C \uC8FC\uB85C \uBC1C\uBCD1\uD55C\uB2E4. \uCC98\uC74C \uC9C8\uBCD1\uC774 \uD655\uC778\uB41C 1976\uB144\uBD80\uD130 2014\uB144\uAE4C\uC9C0 1\uB144\uC5D0 \uC57D \uCC9C\uBA85 \uBBF8\uB9CC\uC774 \uAC10\uC5FC\uB418\uC5C8\uB2E4. \uAC00\uC7A5 \uAC70\uB300\uD55C \uC5D0\uBCFC\uB77C \uC720\uD589\uC740 \uAE30\uB2C8, \uB77C\uC774\uBCA0\uB9AC\uC544, \uC2DC\uC5D0\uB77C\uB9AC\uC628, \uB098\uC774\uC9C0\uB9AC\uC544\uC5D0 \uD37C\uC9C4 2014\uB144 \uC11C\uC544\uD504\uB9AC\uCE74 \uC5D0\uBCFC\uB77C \uC720\uD589\uC774\uB2E4. \uBC31\uC2E0 \uAC1C\uBC1C\uC744 \uC704\uD55C \uB178\uB825\uC774 \uC131\uACF5\uD558\uC5EC 2019\uB144\uBD80\uD130\uB294 \uC5D0\uBCFC\uB77C \uBC31\uC2E0 rVSV-ZEBOV \uC811\uC885\uC744 \uD1B5\uD574 \uC608\uBC29\uC774 \uAC00\uB2A5\uD558\uB2E4."@ko , "La malaltia del virus Ebola (tamb\u00E9 febre hemorr\u00E0gica de l'Ebola, EVD o EHF, segons les inicials en angl\u00E8s), o simplement Ebola, \u00E9s una malaltia dels \u00E9ssers humans i altres primats causada per ebolavirus. Els signes i s\u00EDmptomes solen comen\u00E7ar entre dos dies i tres setmanes despr\u00E9s de contraure el virus com a febre, mal de coll, dolors musculars, i mal de cap. Llavors apareixen v\u00F2mits, diarrea i erupci\u00F3 que generalment segueixen, juntament amb la disminuci\u00F3 de la funci\u00F3 del fetge i els ronyons. En aquest moment algunes persones comencen a sagnar tant interna com externament. La malaltia t\u00E9 un alt risc de mort, matant a entre 25 per cent i el 90 per cent dels infectats amb el virus, amb una mitjana cap a 50 per cent. La mort es dona sovint a causa de la baixa pressi\u00F3 sangu\u00EDnia per la p\u00E8rdua de l\u00EDquids, i en general es produeix 6-16 dies despr\u00E9s que apareguin els s\u00EDmptomes. El primer brot documentat d'Ebola va succeir el 1976 en l'antic Zaire (actualment Rep\u00FAblica Democr\u00E0tica del Congo), on es van detectar 318 casos i 280 morts amb una taxa de mortalitat del 88%. Aquest brot va ser causat pel virus Ebola-Zaire, una de les soques m\u00E9s epid\u00E8miques i mortals de la hist\u00F2ria. Els brots de les febres hemorr\u00E0giques v\u00EDriques tenen una taxa de mortalitat de fins al 90%. El virus es propaga per contacte directe amb sang o altres fluids corporals d'un infectat hum\u00E0 o un altre animal. La infecci\u00F3 amb el virus tamb\u00E9 pot oc\u00F3rrer per contacte directe amb un objecte o superf\u00EDcie recentment contaminats. La propagaci\u00F3 de la malaltia a trav\u00E9s de l'aire no s'ha documentat en el medi natural. L'EBOV es pot propagar pel semen o llet materna durant diverses setmanes o mesos despr\u00E9s de la recuperaci\u00F3. Els ratpenats de la fruita d'\u00C0frica es creu que s\u00F3n el suport normal en la naturalesa, capa\u00E7os de propagar el virus sense ser afectats per ell. Els \u00E9ssers humans s'infecten per contacte amb els ratpenats o amb un animal viu o mort que ha estat infectat pels ratpenats. Despr\u00E9s de produir-se la infecci\u00F3 humana, la malaltia tamb\u00E9 pot disseminar-se entre les persones. Altres malalties, com la mal\u00E0ria, el c\u00F2lera, la febre tifoide, la meningitis i altres febres hemorr\u00E0giques v\u00EDriques poden semblar-se a la malaltia de l'Ebola. Les mostres de sang s'assagen per ARN viral, anticossos virals o per al mateix virus per confirmar el diagn\u00F2stic. El control dels brots requereix serveis m\u00E8dics coordinats, juntament amb un cert nivell de comprom\u00EDs amb la comunitat. Els serveis m\u00E8dics inclouen: la r\u00E0pida detecci\u00F3 dels casos de la malaltia, el rastreig de contactes dels que han estat en contacte amb persones infectades, l'acc\u00E9s r\u00E0pid als serveis de laboratori, cura i maneig dels que estan infectats i la disposici\u00F3 adequada dels morts a trav\u00E9s de la incineraci\u00F3 o l'enterrament. la prevenci\u00F3 inclou la limitaci\u00F3 de la propagaci\u00F3 de malalties d'animals infectats als \u00E9ssers humans. Aix\u00F2 es pot fer pel maneig de carn d'animals silvestres potencialment infectats nom\u00E9s amb roba protectora i per la cocci\u00F3 a fons abans del seu consum. tamb\u00E9 inclou l'\u00FAs de roba protectora adequada i rentada de mans quan s'est\u00E0 al voltant d'una persona amb la malaltia. Les mostres de fluids corporals i teixits de persones amb la malaltia han de ser manejats amb precauci\u00F3 especial. Cap tractament espec\u00EDfic ni vacuna per al virus est\u00E0 disponible al mercat, tot i que s'estan estudiant una s\u00E8rie de tractaments potencials. Els esfor\u00E7os per ajudar a les persones infectades s\u00F3n de suport; que inclouen ja sigui la ter\u00E0pia de rehidrataci\u00F3 oral (begudes lleugerament ensucrades i aigua salada) o l'administraci\u00F3 de l\u00EDquids per via intravenosa, aix\u00ED com tractament dels s\u00EDmptomes. Aquesta atenci\u00F3 de suport millora dels resultats. La malaltia de l'Ebola va ser identificada per primera vegada el 1976 en una zona del Sudan (ara part del Sudan del Sud), i al Zaire (avui Rep\u00FAblica Democr\u00E0tica del Congo). La malaltia generalment es presenta en brots en les regions tropicals de l'\u00C0frica sudsahariana. Durant el 2013, l'Organitzaci\u00F3 Mundial de la Salut va comunicar un total de 1.716 casos en 24 brots. El major brot fins a la data \u00E9s l'epid\u00E8mia en curs a l'\u00C0frica occidental, que se centra a Guinea, Sierra Leone i Lib\u00E8ria."@ca , "\u0411\u043E\u043B\u0435\u0437\u043D\u044C, \u0432\u044B\u0437\u0432\u0430\u043D\u043D\u0430\u044F \u0432\u0438\u0440\u0443\u0441\u043E\u043C \u042D\u0431\u043E\u0301\u043B\u0430 (\u0411\u0412\u0412\u042D, \u0430\u043D\u0433\u043B. Ebola virus disease, EVD), \u0442\u0430\u043A\u0436\u0435 \u0438\u0437\u0432\u0435\u0441\u0442\u043D\u0430\u044F \u043A\u0430\u043A \u0433\u0435\u043C\u043E\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043B\u0438\u0445\u043E\u0440\u0430\u0434\u043A\u0430 \u042D\u0431\u043E\u0301\u043B\u0430 (\u0430\u043D\u0433\u043B. Ebola Haemorrhagic Fever, EHF, \u043B\u0430\u0442. Ebola febris haemorrhagica) \u2014 \u043E\u0441\u0442\u0440\u0430\u044F \u0432\u0438\u0440\u0443\u0441\u043D\u0430\u044F \u0432\u044B\u0441\u043E\u043A\u043E\u043A\u043E\u043D\u0442\u0430\u0433\u0438\u043E\u0437\u043D\u0430\u044F \u0431\u043E\u043B\u0435\u0437\u043D\u044C. \u0420\u0435\u0434\u043A\u043E\u0435, \u043D\u043E \u043A\u0440\u0430\u0439\u043D\u0435 \u043E\u043F\u0430\u0441\u043D\u043E\u0435 \u0437\u0430\u0431\u043E\u043B\u0435\u0432\u0430\u043D\u0438\u0435. \u0412\u0441\u043F\u044B\u0448\u043A\u0438 \u044D\u043F\u0438\u0434\u0435\u043C\u0438\u0438 \u0437\u0430\u0444\u0438\u043A\u0441\u0438\u0440\u043E\u0432\u0430\u043D\u044B \u0432 \u0426\u0435\u043D\u0442\u0440\u0430\u043B\u044C\u043D\u043E\u0439 \u0438 \u0417\u0430\u043F\u0430\u0434\u043D\u043E\u0439 \u0410\u0444\u0440\u0438\u043A\u0435, \u043B\u0435\u0442\u0430\u043B\u044C\u043D\u043E\u0441\u0442\u044C \u0441\u043E\u0441\u0442\u0430\u0432\u043B\u044F\u043B\u0430 \u043E\u0442 25 \u0434\u043E 90 % (\u0432 \u0441\u0440\u0435\u0434\u043D\u0435\u043C 50 %). \u0411\u043E\u043B\u0435\u0437\u043D\u044C \u043F\u043E\u0440\u0430\u0436\u0430\u0435\u0442 \u0442\u043E\u043B\u044C\u043A\u043E \u0447\u0435\u043B\u043E\u0432\u0435\u043A\u0430, \u043D\u0435\u043A\u043E\u0442\u043E\u0440\u044B\u0445 \u043F\u0440\u0438\u043C\u0430\u0442\u043E\u0432, \u0430 \u0442\u0430\u043A\u0436\u0435 \u043F\u0430\u0440\u043D\u043E\u043A\u043E\u043F\u044B\u0442\u043D\u044B\u0445 (\u0432 \u0447\u0430\u0441\u0442\u043D\u043E\u0441\u0442\u0438, \u043F\u043E\u0434\u0442\u0432\u0435\u0440\u0436\u0434\u0435\u043D\u044B \u0441\u043B\u0443\u0447\u0430\u0438 \u043F\u043E\u0440\u0430\u0436\u0435\u043D\u0438\u044F \u0441\u0432\u0438\u043D\u0435\u0439 \u0438 \u0434\u0443\u043A\u0435\u0440\u043E\u0432). \u0412\u0430\u043A\u0446\u0438\u043D\u0430 \u0434\u043B\u044F \u0437\u0430\u0449\u0438\u0442\u044B \u043E\u0442 \u0432\u0438\u0440\u0443\u0441\u0430 \u042D\u0431\u043E\u043B\u0430 \u0434\u043E\u0441\u0442\u0443\u043F\u043D\u0430 \u0432 \u043D\u0435\u0441\u043A\u043E\u043B\u044C\u043A\u0438\u0445 \u0441\u0442\u0440\u0430\u043D\u0430\u0445 \u0441 \u043A\u043E\u043D\u0446\u0430 2019 \u2014 \u043D\u0430\u0447\u0430\u043B\u0430 2022 \u0433\u043E\u0434\u0430."@ru , "Ebola hemoragia febro a\u016D Ebola virusa malsano estas malsano de homoj kaj aliaj primatoj ka\u016Dzita de la Ebolo. Simptomoj montri\u011Das de du tagoj \u011Dis tri semajnoj post infekti\u011Do. Tipaj simptomoj inkluzivas febron, gor\u011Do-doloron, muskolan doloron, kaj kapdoloron. Vomado, erupcioj, kaj diareo sekvas, kune kun difekti\u011Do de la hepato kaj renoj. Proksimume samtempe, infektataj homoj komencos sangi, kaj interne kaj ekstere. Infekti\u011Do povas okazi post kontakto kun sango a\u016D korpaj fluidoj de infektita besto. \u011Cis nun, neniu pruvo ekzistas pri la ebleco, ke la viruso disvasti\u011Dus tra la aero en natura medio. Oni supozas,ke grandkiropteroj (frukto-vespertoj) povas transdoni la viruson sen mem infekti\u011Di. Post homa infekti\u011Do, la viruso povas transiri anka\u016D de homo al homo. Viroj, kiuj travivis la malsanon, eble transdonos la viruson en ilia semo dum du monatoj post resani\u011Do. Por certi\u011Di, ke iu havas la malsanon, oni \u011Denerale devas determini, ke ne temas pri aliaj malsanoj kun similaj simptomoj, ekzemple malario, \u0125olero, kaj aliaj virusaj hemoragiaj febroj. Sekve oni testas sango-specimenon pri la \u0109eesto de virusaj antikorpoj, virusa RNA, a\u016D la viruso mem. Post ekapero, oni limigas la disvasti\u011Don de la malsano per komunuma agado, \u011Dusta traktado de unuopaj malsanuloj, atenta observado kaj identigo de homoj, kiuj estis en la \u0109eesto de malsanulo, bona laboratoria servo, kaj \u011Dusta enterigo de korpoj de mortintoj. Oni povas malebligi la infekti\u011Don per malhelpo de transi\u011Do de la viruso de bestoj al homoj. Tion oni faras per la kontrolado de la bestoj pri la viruso, kaj mortigado kaj \u011Dusta traktado de la korpoj de infektitaj. Helpas anka\u016D korekta kuirado de viandoj. La portado de protektaj vestoj dum la \u0109eesto de malsanuloj kaj la ofta mano-lavado estas aliaj protektaj rimedoj. Neniu specifa traktado por la malsano estas ankora\u016D disponebla. Oni helpas malsanulojn per subtenaj rimedoj, ekzemple trinka\u0135oj de iomete dol\u0109a kaj sala akvo, a\u016D envejnigataj fluidoj. \u0108i-tiu subtena terapio atingas pli bonan rezulton. La malsano mortigas inter 25% kaj 90% de tiuj, kiuj infekti\u011Das per la viruso (meznombre 50%). Ebola virusa malsano unue estis identigita en regiono de Sudano, kiu nun estas parto de Sud-Sudano, kaj anka\u016D en Zairo (kiu nun nomi\u011Das Demokratia Respubliko Kongo). La malsano tipe ekaperas en tropikaj regionoj de Afriko sude de Saharo. De 1976 (kiam \u011Di unue estis identigita), \u011Dis 2013, la Monda Organiza\u0135o pri Sano raportis pri 1,716 kazoj. La plej granda epidemio en la historio estas la nuna Ebola epidemio en Okcidentafriko (2014), kiu ampleksas Gvineon, Sieraleonon, Liberion, kaj Nigerion, kun kazoj (la 9-an de oktobro 2014) en Usono, kaj Hispanio. \u011Cis la 10-a de oktobro 2014, oni raportis pri 8,376 suspektataj kazoj, kiuj rezultis 4,024 mortojn. Esploroj por trovi vakcinon progresas, sed \u011Dis nun neniu ekzistas."@eo , "\u0397 \u039D\u03CC\u03C3\u03BF\u03C2 \u03C4\u03BF\u03C5 \u0388\u03BC\u03C0\u03BF\u03BB\u03B1 (EVD) \u03AE \u03B1\u03B9\u03BC\u03BF\u03C1\u03C1\u03B1\u03B3\u03B9\u03BA\u03CC\u03C2 \u03C0\u03C5\u03C1\u03B5\u03C4\u03CC\u03C2 \u0388\u03BC\u03C0\u03BF\u03BB\u03B1 (EHF) \u03B5\u03AF\u03BD\u03B1\u03B9 \u03BC\u03B9\u03B1 \u03B1\u03BD\u03B8\u03C1\u03CE\u03C0\u03B9\u03BD\u03B7 \u03BD\u03CC\u03C3\u03BF\u03C2 \u03C0\u03BF\u03C5 \u03C0\u03C1\u03BF\u03BA\u03B1\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03BF\u03BD . \u03A4\u03B1 \u03C3\u03C5\u03BC\u03C0\u03C4\u03CE\u03BC\u03B1\u03C4\u03B1 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B4\u03CD\u03BF \u03BC\u03AD\u03C1\u03B5\u03C2 \u03AD\u03C9\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03C1\u03B5\u03B9\u03C2 \u03B5\u03B2\u03B4\u03BF\u03BC\u03AC\u03B4\u03B5\u03C2 \u03BC\u03B5\u03C4\u03AC \u03C4\u03B7\u03BD \u03B5\u03C0\u03B1\u03C6\u03AE \u03BC\u03B5 \u03C4\u03BF\u03BD \u03B9\u03CC \u03BA\u03B1\u03B9 \u03C3\u03B5 \u03B1\u03C5\u03C4\u03AC \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C0\u03C5\u03C1\u03B5\u03C4\u03CC\u03C2, \u03C0\u03BF\u03BD\u03CC\u03BB\u03B1\u03B9\u03BC\u03BF\u03C2, \u03BA\u03B1\u03B9 \u03C0\u03BF\u03BD\u03BF\u03BA\u03AD\u03C6\u03B1\u03BB\u03BF\u03C2. \u03A3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2, \u03C3\u03C5\u03BD\u03BF\u03B4\u03B5\u03CD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03BD\u03B1\u03C5\u03C4\u03AF\u03B1, \u03B5\u03BC\u03B5\u03C4\u03CC \u03BA\u03B1\u03B9 \u03B4\u03B9\u03AC\u03C1\u03C1\u03BF\u03B9\u03B1, \u03BA\u03B1\u03B9 \u03C4\u03B1\u03C5\u03C4\u03CC\u03C7\u03C1\u03BF\u03BD\u03B1 \u03BC\u03B5\u03B9\u03C9\u03BC\u03AD\u03BD\u03B7 \u03BB\u03B5\u03B9\u03C4\u03BF\u03C5\u03C1\u03B3\u03AF\u03B1 \u03C4\u03BF\u03C5 \u03C3\u03C5\u03BA\u03C9\u03C4\u03B9\u03BF\u03CD \u03BA\u03B1\u03B9 \u03C4\u03BF\u03C5/\u03C4\u03C9\u03BD \u03BD\u03B5\u03C6\u03C1\u03BF\u03CD/\u03CE\u03BD. \u03A3\u03B5 \u03B1\u03C5\u03C4\u03CC \u03C4\u03BF \u03C3\u03C4\u03AC\u03B4\u03B9\u03BF, \u03BF\u03C1\u03B9\u03C3\u03BC\u03AD\u03BD\u03B1 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03B1\u03C1\u03C7\u03AF\u03B6\u03BF\u03C5\u03BD \u03BD\u03B1 \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03C5\u03BD \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03B1\u03B9\u03BC\u03BF\u03C1\u03C1\u03B1\u03B3\u03AF\u03B1\u03C2. \u039F \u03B9\u03CC\u03C2 \u03BC\u03C0\u03BF\u03C1\u03B5\u03AF \u03BD\u03B1 \u03BC\u03B5\u03C4\u03B1\u03B4\u03BF\u03B8\u03B5\u03AF \u03BC\u03B5\u03C4\u03AC \u03B1\u03C0\u03CC \u03B5\u03C0\u03B1\u03C6\u03AE \u03BC\u03B5 \u03C4\u03BF \u03B1\u03AF\u03BC\u03B1 \u03AE \u03BC\u03B5 \u03C4\u03B1 \u03BA\u03AC\u03C0\u03BF\u03B9\u03BF\u03C5 \u03BC\u03BF\u03BB\u03C5\u03C3\u03BC\u03AD\u03BD\u03BF\u03C5 \u03B6\u03CE\u03BF\u03C5 (\u03BA\u03C5\u03C1\u03AF\u03C9\u03C2 \u03C0\u03AF\u03B8\u03B7\u03BA\u03BF\u03B9 \u03AE \u03C6\u03C1\u03BF\u03C5\u03C4\u03BF\u03C6\u03AC\u03B3\u03B1 \u03C7\u03B5\u03B9\u03C1\u03CC\u03C0\u03C4\u03B5\u03C1\u03B1.) \u0394\u03B5\u03BD \u03AD\u03C7\u03B5\u03B9 \u03C4\u03B5\u03BA\u03BC\u03B7\u03C1\u03B9\u03C9\u03B8\u03B5\u03AF \u03B7 \u03B4\u03B9\u03AC\u03B4\u03BF\u03C3\u03B7 \u03BC\u03AD\u03C3\u03C9 \u03C4\u03BF\u03C5 \u03B1\u03AD\u03C1\u03B1 \u03C3\u03C4\u03BF \u03C6\u03C5\u03C3\u03B9\u03BA\u03CC \u03C0\u03B5\u03C1\u03B9\u03B2\u03AC\u03BB\u03BB\u03BF\u03BD. \u03A0\u03B9\u03C3\u03C4\u03B5\u03CD\u03B5\u03C4\u03B1\u03B9 \u03CC\u03C4\u03B9 \u03C4\u03B1 \u03C6\u03C1\u03BF\u03C5\u03C4\u03BF\u03C6\u03AC\u03B3\u03B1 \u03C7\u03B5\u03B9\u03C1\u03CC\u03C0\u03C4\u03B5\u03C1\u03B1 \u03BC\u03B5\u03C4\u03B1\u03C6\u03AD\u03C1\u03BF\u03C5\u03BD \u03BA\u03B1\u03B9 \u03BC\u03B5\u03C4\u03B1\u03B4\u03AF\u03B4\u03BF\u03C5\u03BD \u03C4\u03BF\u03BD \u03B9\u03CC, \u03C7\u03C9\u03C1\u03AF\u03C2 \u03BD\u03B1 \u03BC\u03BF\u03BB\u03C5\u03BD\u03B8\u03BF\u03CD\u03BD. \u039C\u03CC\u03BB\u03B9\u03C2 \u03B5\u03C0\u03AD\u03BB\u03B8\u03B5\u03B9 \u03BC\u03CC\u03BB\u03C5\u03BD\u03C3\u03B7 \u03C3\u03B5 \u03B1\u03BD\u03B8\u03C1\u03CE\u03C0\u03B9\u03BD\u03BF \u03BF\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03CC, \u03B7 \u03BD\u03CC\u03C3\u03BF\u03C2 \u03BC\u03C0\u03BF\u03C1\u03B5\u03AF \u03BD\u03B1 \u03B5\u03BE\u03B1\u03C0\u03BB\u03C9\u03B8\u03B5\u03AF \u03BA\u03B1\u03B9 \u03BC\u03B5\u03C4\u03B1\u03BE\u03CD \u03C4\u03C9\u03BD \u03B1\u03BD\u03B8\u03C1\u03CE\u03C0\u03C9\u03BD. \u039F\u03B9 \u03AC\u03BD\u03C4\u03C1\u03B5\u03C2 \u03B5\u03C0\u03B9\u03B6\u03CE\u03BD\u03C4\u03B5\u03C2 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03B5 \u03B8\u03AD\u03C3\u03B7 \u03BD\u03B1 \u03BC\u03B5\u03C4\u03B1\u03B4\u03CE\u03C3\u03BF\u03C5\u03BD \u03C4\u03B7 \u03BD\u03CC\u03C3\u03BF \u03BC\u03AD\u03C3\u03C9 \u03C4\u03BF\u03C5 \u03C3\u03C0\u03AD\u03C1\u03BC\u03B1\u03C4\u03BF\u03C2 \u03B5\u03C0\u03AF \u03C3\u03C7\u03B5\u03B4\u03CC\u03BD \u03B4\u03CD\u03BF \u03BC\u03AE\u03BD\u03B5\u03C2. \u0393\u03B9\u03B1 \u03BD\u03B1 \u03B3\u03AF\u03BD\u03B5\u03B9 \u03B7 \u03B4\u03B9\u03AC\u03B3\u03BD\u03C9\u03C3\u03B7, \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03B5\u03BE\u03B1\u03B9\u03C1\u03BF\u03CD\u03BD\u03C4\u03B1\u03B9 \u03C0\u03C1\u03CE\u03C4\u03B1 \u03AC\u03BB\u03BB\u03B5\u03C2 \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B5\u03C2 \u03BC\u03B5 \u03C0\u03B1\u03C1\u03CC\u03BC\u03BF\u03B9\u03B1 \u03C3\u03C5\u03BC\u03C0\u03C4\u03CE\u03BC\u03B1\u03C4\u03B1, \u03CC\u03C0\u03C9\u03C2 \u03B5\u03BB\u03BF\u03BD\u03BF\u03C3\u03AF\u03B1, \u03C7\u03BF\u03BB\u03AD\u03C1\u03B1 \u03BA\u03B1\u03B9 \u03AC\u03BB\u03BB\u03BF\u03B9 \u03B9\u03BF\u03B3\u03B5\u03BD\u03B5\u03AF\u03C2 \u03B1\u03B9\u03BC\u03BF\u03C1\u03C1\u03B1\u03B3\u03B9\u03BA\u03BF\u03AF \u03C0\u03C5\u03C1\u03B5\u03C4\u03BF\u03AF. \u03A0\u03C1\u03BF\u03BA\u03B5\u03B9\u03BC\u03AD\u03BD\u03BF\u03C5 \u03BD\u03B1 \u03B5\u03C0\u03B9\u03B2\u03B5\u03B2\u03B1\u03B9\u03C9\u03B8\u03B5\u03AF \u03B7 \u03B4\u03B9\u03AC\u03B3\u03BD\u03C9\u03C3\u03B7, \u03C4\u03B1 \u03B4\u03B5\u03AF\u03B3\u03BC\u03B1\u03C4\u03B1 \u03B1\u03AF\u03BC\u03B1\u03C4\u03BF\u03C2 \u03B5\u03BB\u03AD\u03B3\u03C7\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03B9\u03BF\u03B3\u03B5\u03BD\u03AE \u03B1\u03BD\u03C4\u03B9\u03C3\u03CE\u03BC\u03B1\u03C4\u03B1, \u03B9\u03B9\u03BA\u03CC RNA, \u03AE \u03B3\u03B9\u03B1 \u03C4\u03BF\u03BD \u03B9\u03CC \u03BA\u03B1\u03B8\u03B1\u03C5\u03C4\u03CC\u03BD. \u0394\u03B5\u03BD \u03C5\u03C0\u03AC\u03C1\u03C7\u03B5\u03B9 \u03B5\u03B9\u03B4\u03B9\u03BA\u03AE \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1. \u03A3\u03C4\u03B9\u03C2 \u03C0\u03C1\u03BF\u03C3\u03C0\u03AC\u03B8\u03B5\u03B9\u03B5\u03C2 \u03B3\u03B9\u03B1 \u03C0\u03B1\u03C1\u03BF\u03C7\u03AE \u03B2\u03BF\u03AE\u03B8\u03B5\u03B9\u03B1\u03C2 \u03C3\u03B5 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03C0\u03BF\u03C5 \u03AD\u03C7\u03BF\u03C5\u03BD \u03BC\u03BF\u03BB\u03C5\u03BD\u03B8\u03B5\u03AF \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B5\u03AF\u03C4\u03B5 \u03B7 \u03B1\u03C0\u03CC \u03C4\u03BF\u03C5 \u03C3\u03C4\u03CC\u03BC\u03B1\u03C4\u03BF\u03C2 \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 (\u03B7 \u03C0\u03CC\u03C3\u03B7 \u03B5\u03BB\u03B1\u03C6\u03C1\u03CE\u03C2 \u03B3\u03BB\u03C5\u03BA\u03BF\u03CD \u03AE \u03B1\u03BB\u03BC\u03C5\u03C1\u03BF\u03CD \u03BD\u03B5\u03C1\u03BF\u03CD) \u03AE \u03C4\u03B1 \u03C5\u03B3\u03C1\u03AC \u03BC\u03B5 \u03B5\u03BD\u03B4\u03BF\u03C6\u03BB\u03AD\u03B2\u03B9\u03B1 \u03AD\u03B3\u03C7\u03C5\u03C3\u03B7. \u0397 \u03BD\u03CC\u03C3\u03BF\u03C2 \u03AD\u03C7\u03B5\u03B9 \u03C5\u03C8\u03B7\u03BB\u03AC \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03AC \u03B8\u03BD\u03B7\u03C3\u03B9\u03BC\u03CC\u03C4\u03B7\u03C4\u03B1\u03C2: \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03CC 50% \u03AD\u03C9\u03C2 \u03BA\u03B1\u03B9 90% \u03C4\u03C9\u03BD \u03B1\u03C4\u03CC\u03BC\u03C9\u03BD \u03C0\u03BF\u03C5 \u03BC\u03BF\u03BB\u03CD\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03BF\u03BD \u03B9\u03CC, \u03BA\u03B1\u03C4\u03B1\u03BB\u03AE\u03B3\u03B5\u03B9 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03C3\u03C4\u03BF\u03BD \u03B8\u03AC\u03BD\u03B1\u03C4\u03BF. \u03A4\u03BF EVD \u03B5\u03BD\u03C4\u03BF\u03C0\u03AF\u03C3\u03C4\u03B7\u03BA\u03B5 \u03B3\u03B9\u03B1 \u03C0\u03C1\u03CE\u03C4\u03B7 \u03C6\u03BF\u03C1\u03AC \u03C3\u03C4\u03BF \u03A3\u03BF\u03C5\u03B4\u03AC\u03BD \u03BA\u03B1\u03B9 \u03C4\u03B7 \u039B\u03B1\u03CA\u03BA\u03AE \u0394\u03B7\u03BC\u03BF\u03BA\u03C1\u03B1\u03C4\u03AF\u03B1 \u03C4\u03BF\u03C5 \u039A\u03BF\u03BD\u03B3\u03BA\u03CC. \u039A\u03C1\u03BF\u03CD\u03C3\u03BC\u03B1\u03C4\u03B1 \u03C4\u03B7\u03C2 \u03BD\u03CC\u03C3\u03BF\u03C5 \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C3\u03C5\u03BD\u03AE\u03B8\u03C9\u03C2 \u03C3\u03B5 \u03C4\u03C1\u03BF\u03C0\u03B9\u03BA\u03AD\u03C2 \u03C0\u03B5\u03C1\u03B9\u03BF\u03C7\u03AD\u03C2 \u03C4\u03B7\u03C2 \u03A5\u03C0\u03BF\u03C3\u03B1\u03C7\u03AC\u03C1\u03B9\u03B1\u03C2 \u0391\u03C6\u03C1\u03B9\u03BA\u03AE\u03C2. \u0391\u03C0\u03CC \u03C4\u03BF 1976 \u03CC\u03C4\u03B1\u03BD \u03B5\u03BD\u03C4\u03BF\u03C0\u03AF\u03C3\u03C4\u03B7\u03BA\u03B5 \u03B3\u03B9\u03B1 \u03C0\u03C1\u03CE\u03C4\u03B7 \u03C6\u03BF\u03C1\u03AC, \u03AD\u03C9\u03C2 \u03C4\u03BF 2013, \u03AD\u03C7\u03BF\u03C5\u03BD \u03BC\u03BF\u03BB\u03C5\u03BD\u03B8\u03B5\u03AF \u03BB\u03B9\u03B3\u03CC\u03C4\u03B5\u03C1\u03B1 \u03B1\u03C0\u03CC 1.000 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03B1\u03BD\u03AC \u03AD\u03C4\u03BF\u03C2. \u0397 \u03BC\u03B5\u03B3\u03B1\u03BB\u03CD\u03C4\u03B5\u03C1\u03B7 \u03AD\u03BE\u03B1\u03C1\u03C3\u03B7 \u03BC\u03AD\u03C7\u03C1\u03B9 \u03C3\u03AE\u03BC\u03B5\u03C1\u03B1 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B7 \u03C3\u03C5\u03BD\u03B5\u03C7\u03B9\u03B6\u03CC\u03BC\u03B5\u03BD\u03B7 \u0388\u03BE\u03B1\u03C1\u03C3\u03B7 \u03C4\u03BF\u03C5 \u03B9\u03BF\u03CD \u0388\u03BC\u03C0\u03BF\u03BB\u03B1 2014, \u03B7 \u03BF\u03C0\u03BF\u03AF\u03B1 \u03B5\u03C0\u03B7\u03C1\u03B5\u03AC\u03B6\u03B5\u03B9 \u03C4\u03B7 \u0393\u03BF\u03C5\u03B9\u03BD\u03AD\u03B1, \u03C4\u03B7 \u03A3\u03B9\u03AD\u03C1\u03B1 \u039B\u03B5\u03CC\u03BD\u03B5, \u03C4\u03B7 \u039B\u03B9\u03B2\u03B5\u03C1\u03AF\u03B1 \u03BA\u03B1\u03B9 \u03C4\u03B7 \u039D\u03B9\u03B3\u03B7\u03C1\u03AF\u03B1. \u0389\u03B4\u03B7, \u03C4\u03BF\u03BD \u0391\u03CD\u03B3\u03BF\u03C5\u03C3\u03C4\u03BF \u03C4\u03BF\u03C5 2014 \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BD\u03C4\u03BF\u03C0\u03B9\u03C3\u03C4\u03B5\u03AF \u03C0\u03B5\u03C1\u03B9\u03C3\u03C3\u03CC\u03C4\u03B5\u03C1\u03B1 \u03B1\u03C0\u03CC 1.600 \u03BA\u03C1\u03BF\u03CD\u03C3\u03BC\u03B1\u03C4\u03B1. \u039F\u03B9 \u03C0\u03C1\u03BF\u03C3\u03C0\u03AC\u03B8\u03B5\u03B9\u03B5\u03C2 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03B4\u03B7\u03BC\u03B9\u03BF\u03C5\u03C1\u03B3\u03AF\u03B1 \u03B5\u03BD\u03CC\u03C2 \u03B5\u03BC\u03B2\u03BF\u03BB\u03AF\u03BF\u03C5 \u03C3\u03C5\u03BD\u03B5\u03C7\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9, \u03C9\u03C3\u03C4\u03CC\u03C3\u03BF, \u03C4\u03BF \u03BA\u03B1\u03C4\u03AC\u03BB\u03BB\u03B7\u03BB\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03B4\u03B5\u03BD \u03AD\u03C7\u03B5\u03B9 \u03B1\u03BD\u03B1\u03C0\u03C4\u03C5\u03C7\u03B8\u03B5\u03AF \u03B1\u03BA\u03CC\u03BC\u03B1."@el , "Ebola (t\u00E9\u017E krv\u00E1civ\u00E1 hore\u010Dka ebola) je virov\u00E9 onemocn\u011Bn\u00ED ze skupiny krv\u00E1civ\u00FDch (hemoragick\u00FDch) hore\u010Dek, kter\u00E9 napad\u00E1 lidi a n\u011Bkter\u00E9 dal\u0161\u00ED prim\u00E1ty. P\u0159edstavuje jednu z nejnebezpe\u010Dn\u011Bj\u0161\u00EDch n\u00E1kaz, s jakou se kdy lidstvo setkalo. P\u016Fvodcem onemocn\u011Bn\u00ED je filovirus ebola. Dosud nejv\u011Bt\u0161\u00ED epidemie t\u00E9to nemoci s nejv\u011Bt\u0161\u00EDm po\u010Dtem \u00FAmrt\u00ED propukla v z\u00E1padn\u00ED Africe v prosinci 2013, detekov\u00E1na byla v\u0161ak a\u017E v b\u0159eznu roku 2014. Symptomy se obvykle za\u010D\u00EDnaj\u00ED projevovat n\u011Bkolik dn\u00ED a\u017E t\u0159i t\u00FDdny po n\u00E1kaze virem, a to hore\u010Dkou, bolest\u00ED v krku, a bolest\u00ED hlavy. D\u00E1le typicky n\u00E1sleduje nevolnost, zvracen\u00ED a pr\u016Fjem, spole\u010Dn\u011B se zhor\u0161en\u00FDm fungov\u00E1n\u00EDm jater a ledvin. V t\u00E9to f\u00E1zi za\u010D\u00EDnaj\u00ED m\u00EDt n\u011Bkte\u0159\u00ED lid\u00E9 probl\u00E9my s krv\u00E1cen\u00EDm. Virus ebola se poprv\u00E9 objevil v roce 1976 a od t\u00E9 doby r\u016Fzn\u00E9 kmeny viru ebola zp\u016Fsobuj\u00ED epidemie s m\u00EDrou letality dosahuj\u00EDc\u00ED 50\u201390 %. M\u00EDstem epidemi\u00ED byly p\u0159edev\u0161\u00EDm africk\u00E9 zem\u011B Kon\u017Esk\u00E1 demokratick\u00E1 republika, Kon\u017Esk\u00E1 republika, Gabon, Uganda a S\u00FAd\u00E1n, b\u011Bhem \u017E\u00E1dn\u00E9 z jednotliv\u00FDch epidemi\u00ED nebylo naka\u017Eeno v\u00EDce ne\u017E 500 osob. V roce 2013 vypukla rozs\u00E1hl\u00E1 epidemie v z\u00E1padoafrick\u00E9 Guineji, kter\u00E1 se roz\u0161\u00ED\u0159ila do sousedn\u00ED Lib\u00E9rie, Sierry Leone, Mali a Senegalu i do nedalek\u00E9 Nig\u00E9rie. Epidemie skon\u010Dila a\u017E v roce 2016, po\u010Det naka\u017Een\u00FDch p\u0159es\u00E1hl 28 000 lid\u00ED a po\u010Det mrtv\u00FDch 11 000 lid\u00ED. V sou\u010Dasnosti je zn\u00E1mo 5 kmen\u016F viru ebola. T\u0159i z nich (ebola-Zair, ebola-S\u00FAd\u00E1n a ebola-Bundibugyo) napadaj\u00ED \u010Dlov\u011Bka. \u010Ctvrt\u00FD kmen (ebola-Pob\u0159e\u017E\u00ED slonoviny, anglicky Ta\u00EF Forest ebolavirus) dosud zp\u016Fsobil jen jedno zaznamenan\u00E9 lidsk\u00E9 onemocn\u011Bn\u00ED, kdy\u017E do\u0161lo k p\u0159enosu choroby z pitvan\u00E9ho \u0161impanze, a nebylo smrteln\u00E9. P\u00E1t\u00FD kmen (ebola-Reston) napad\u00E1 opice a prasata. Jm\u00E9no ebola bylo p\u0159evzato od \u0159eky, kter\u00E1 prot\u00E9k\u00E1 oblast\u00ED, v n\u00ED\u017E propukla prvn\u00ED epidemie t\u00E9to nemoci."@cs , "Ebola, f\u00F6rkortat EVD (Ebola Virus Disease), \u00E4r en epidemisk sjukdom som orsakas av ebolavirus. Namnet kommer fr\u00E5n Ebolafloden i Demokratiska Republiken Kongo, d\u00E4r de f\u00F6rsta utbrotten \u00E4gde rum 1976, samtidigt med utbrott i Nzara i Sudan. Ebolafebern \u00E4r en bl\u00F6darfeber d\u00E4r viruset p\u00E5verkar endotelcellerna i blodk\u00E4rlen och minskar koagulationsf\u00F6rm\u00E5gan, vilket leder till att blod l\u00E4cker ur blodk\u00E4rlen och kroppen hamnar i hypovolemisk chock (cirkulationssvikt). Sjukdomen smittar via kroppsv\u00E4tskor och \u00E4r mycket d\u00F6dlig. Virusstammen Ebola zaire har en d\u00F6dlighet p\u00E5 80 procent."@sv , "Ebolafieber, nach ICD-10 Ebola-Viruskrankheit, ist eine Infektionskrankheit, die durch Viren der Gattung Ebolavirus hervorgerufen wird. Die Bezeichnung geht auf den Fluss Ebola in der Demokratischen Republik Kongo zur\u00FCck, in dessen N\u00E4he diese Viren 1976 den ersten allgemein bekannten gro\u00DFen Ausbruch verursacht hatten. Von 2014 bis 2016 gab es die weltweit bislang schwerste Ebolafieber-Epidemie in Westafrika. Das Ebolafieber ist eine Zoonose und verl\u00E4uft je nach Virusart in etwa 25 bis 90 % aller F\u00E4lle t\u00F6dlich, wobei die durchschnittliche Fallsterblichkeitsrate bei 50 % liegt. Als Therapie stehen bislang Ma\u00DFnahmen zur Bek\u00E4mpfung oder Linderung einzelner Krankheitssymptome zur Verf\u00FCgung. Zur Prophylaxe werden Impfungen genutzt. In Deutschland, \u00D6sterreich, der Schweiz und in vielen anderen L\u00E4ndern besteht eine Meldepflicht bei Verdacht auf Ebolafieber, bei direktem oder indirektem Erregernachweis, bei Ausbruch der Erkrankung, beim h\u00E4morrhagischen Krankheitsverlauf oder bei Tod durch die Ebola-Virus-Krankheit. F\u00FCr die Erkrankung von Affen besteht in Deutschland Anzeigepflicht nach dem Tiergesundheitsgesetz (TierGesG)."@de , "\u0425\u0432\u043E\u0440\u043E\u0301\u0431\u0430, \u044F\u043A\u0443 \u0441\u043F\u0440\u0438\u0447\u0438\u0301\u043D\u044E\u0454 \u0432\u0456\u0301\u0440\u0443\u0441 \u0415\u0301\u0301\u0431\u043E\u0301\u043B\u0430 (\u0433\u0430\u0440\u044F\u0447\u043A\u0430 \u0415\u0431\u043E\u043B\u0430, \u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u0430 \u0433\u0430\u0440\u044F\u0447\u043A\u0430 \u0415\u0431\u043E\u043B\u0430, \u0430\u043D\u0433\u043B. Ebola fever, \u043B\u0430\u0442. febris Ebola) \u2014 \u0433\u043E\u0441\u0442\u0440\u0430 \u0432\u0456\u0440\u0443\u0441\u043D\u0430 \u0432\u0438\u0441\u043E\u043A\u043E\u043A\u043E\u043D\u0442\u0430\u0433\u0456\u043E\u0437\u043D\u0430 \u043F\u0440\u0438\u0440\u043E\u0434\u043D\u043E-\u043E\u0441\u0435\u0440\u0435\u0434\u043A\u043E\u0432\u0430 \u0445\u0432\u043E\u0440\u043E\u0431\u0430, \u044F\u043A\u0430 \u0445\u0430\u0440\u0430\u043A\u0442\u0435\u0440\u0438\u0437\u0443\u0454\u0442\u044C\u0441\u044F \u0447\u0430\u0441\u0442\u043E \u0442\u044F\u0436\u043A\u0438\u043C \u043F\u0435\u0440\u0435\u0431\u0456\u0433\u043E\u043C, \u0432\u0438\u0441\u043E\u043A\u043E\u044E \u043B\u0435\u0442\u0430\u043B\u044C\u043D\u0456\u0441\u0442\u044E, \u0432\u0438\u0440\u0430\u0436\u0435\u043D\u043E\u044E \u0456\u043D\u0442\u043E\u043A\u0441\u0438\u043A\u0430\u0446\u0456\u0454\u044E, \u0437\u043D\u0435\u0432\u043E\u0434\u043D\u0435\u043D\u043D\u044F\u043C, \u0443\u0440\u0430\u0436\u0435\u043D\u043D\u044F\u043C \u043A\u0440\u043E\u0432\u043E\u043D\u043E\u0441\u043D\u0438\u0445 \u0441\u0443\u0434\u0438\u043D \u0431\u0430\u0433\u0430\u0442\u044C\u043E\u0445 \u043E\u0440\u0433\u0430\u043D\u0456\u0432 \u0456\u0437 \u0440\u043E\u0437\u0432\u0438\u0442\u043A\u043E\u043C \u0442\u044F\u0436\u043A\u043E\u0433\u043E \u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u0441\u0438\u043D\u0434\u0440\u043E\u043C\u0443. \u0412\u043E\u043D\u0430 \u0432\u0445\u043E\u0434\u0438\u0442\u044C \u0434\u043E \u043F\u0435\u0440\u0435\u043B\u0456\u043A\u0443 \u0445\u0432\u043E\u0440\u043E\u0431, \u044F\u043A\u0456 \u0437\u0434\u0430\u0442\u043D\u0456 \u0441\u0435\u0440\u0439\u043E\u0437\u043D\u043E \u0432\u043F\u043B\u0438\u0432\u0430\u0442\u0438 \u043D\u0430 \u0437\u0434\u043E\u0440\u043E\u0432'\u044F \u043D\u0430\u0441\u0435\u043B\u0435\u043D\u043D\u044F \u0456 \u043C\u043E\u0436\u0443\u0442\u044C \u0448\u0432\u0438\u0434\u043A\u043E \u043F\u043E\u0448\u0438\u0440\u044E\u0432\u0430\u0442\u0438\u0441\u044F \u0432 \u043C\u0456\u0436\u043D\u0430\u0440\u043E\u0434\u043D\u0438\u0445 \u043C\u0430\u0441\u0448\u0442\u0430\u0431\u0430\u0445. \u041A\u0440\u0456\u043C \u0442\u043E\u0433\u043E, \u0445\u0432\u043E\u0440\u043E\u0431\u0430, \u044F\u043A\u0443 \u0441\u043F\u0440\u0438\u0447\u0438\u043D\u044E\u0454 \u0432\u0456\u0440\u0443\u0441 \u0415\u0431\u043E\u043B\u0430, \u0443\u0432\u0456\u0439\u0448\u043B\u0430 \u0434\u043E \u043F\u0435\u0440\u0435\u043B\u0456\u043A\u0443 \u043F\u043E\u0434\u0456\u0439, \u044F\u043A\u0456 \u043C\u043E\u0436\u0443\u0442\u044C \u044F\u0432\u043B\u044F\u0442\u0438 \u043D\u0430\u0434\u0437\u0432\u0438\u0447\u0430\u0439\u043D\u0443 \u0441\u0438\u0442\u0443\u0430\u0446\u0456\u044E \u0432 \u0433\u0430\u043B\u0443\u0437\u0456 \u043E\u0445\u043E\u0440\u043E\u043D\u0438 \u0437\u0434\u043E\u0440\u043E\u0432'\u044F, \u0442\u0430 \u044F\u043A\u0456 \u0440\u0435\u0433\u0443\u043B\u044E\u044E\u0442\u044C \u0441\u0443\u0447\u0430\u0441\u043D\u0456 \u041C\u0456\u0436\u043D\u0430\u0440\u043E\u0434\u043D\u0456 \u043C\u0435\u0434\u0438\u043A\u043E-\u0441\u0430\u043D\u0456\u0442\u0430\u0440\u043D\u0456 \u043F\u0440\u0430\u0432\u0438\u043B\u0430 2005 \u0440\u043E\u043A\u0443. \u0417\u0431\u0443\u0434\u043D\u0438\u043A\u0430 \u0445\u0432\u043E\u0440\u043E\u0431\u0438 \u0432\u043D\u0435\u0441\u0435\u043D\u043E \u0434\u043E \u0447\u0438\u043D\u043D\u0438\u043A\u0456\u0432 \u0431\u0456\u043E\u043B\u043E\u0433\u0456\u0447\u043D\u043E\u0457 \u0437\u0431\u0440\u043E\u0457 \u0443 \u043F\u0435\u0440\u0435\u043B\u0456\u043A\u0443 \u00AB\u0411\u0456\u043E\u043B\u043E\u0433\u0456\u0447\u043D\u0438\u0445 \u0430\u0433\u0435\u043D\u0442\u0456\u0432, \u044F\u043A\u0456 \u0446\u0438\u0442\u0443\u044E\u0442\u044C \u043F\u0456\u0434 \u0440\u0456\u0437\u043D\u0438\u043C\u0438 \u043D\u0430\u0437\u0432\u0430\u043C\u0438, \u044F\u043A \u0437\u0431\u0440\u043E\u044E \u0434\u043B\u044F \u0443\u0440\u0430\u0436\u0435\u043D\u043D\u044F \u0436\u0438\u0432\u043E\u0457 \u0441\u0438\u043B\u0438\u00BB"@uk , "La maladie \u00E0 virus Ebola, \u00E9galement appel\u00E9e fi\u00E8vre h\u00E9morragique Ebola ou fi\u00E8vre d\u2019Ebola (en anglais : Ebola virus disease ou EVD), est la maladie provoqu\u00E9e par le virus Ebola, qui touche les primates et d'autres animaux tels que le porc. Il s'agit d'une fi\u00E8vre h\u00E9morragique virale aigu\u00EB accompagn\u00E9e d'une atteinte s\u00E9v\u00E8re de l'h\u00E9mostase et du syst\u00E8me immunitaire conduisant \u00E0 une grave immunod\u00E9pression. Pr\u00E9sentant un tableau clinique identique \u00E0 celui des affections \u00E0 virus Marburg, la maladie \u00E0 virus Ebola est r\u00E9put\u00E9e plus grave et le plus souvent mortelle chez l'homme, avec un taux de l\u00E9talit\u00E9 atteignant parfois 90 % lors des flamb\u00E9es \u00E9pid\u00E9miques. Ces derni\u00E8res surviennent principalement dans les villages isol\u00E9s d'Afrique centrale et d'Afrique de l'Ouest, \u00E0 proximit\u00E9 des for\u00EAts de feuillus humides tropicales et subtropicales. Aucun facteur de pr\u00E9disposition \u00E0 l'infection n'a \u00E9t\u00E9 identifi\u00E9 ; toutefois, les personnes de 20 \u00E0 30 ans semblent particuli\u00E8rement sensibles au virus. Il n'existe pas encore de vaccin ni de traitement sp\u00E9cifique homologu\u00E9, bien que plusieurs d'entre eux soient localement en cours d'essais cliniques sous le contr\u00F4le de l'OMS contre l'\u00E9pid\u00E9mie apparue en Afrique de l'Ouest en 2014, tels que le cAd3-ZEBOV, le VSV-EBOV, le favipiravir (Avigan), ou encore le brincidofovir. La prise en charge des personnes atteintes repose avant tout sur des soins palliatifs intensifs. Le virus se transmet \u00E0 l'homme \u00E0 partir d'animaux sauvages et circule ensuite au sein des populations humaines par contact avec les fluides corporels de personnes pr\u00E9sentant les sympt\u00F4mes de la maladie (\u00E0 l'issue de la p\u00E9riode d'incubation), voire par voie ent\u00E9rale, mais pas par a\u00E9rosols (voie a\u00E9rienne). Des chercheurs pensent que des chauves-souris frugivores de la famille des pt\u00E9ropodid\u00E9s constituent le r\u00E9servoir naturel du virus Ebola, bien que les porcs aient \u00E9t\u00E9 \u00E9galement impliqu\u00E9s dans la transmission d'un virus de m\u00EAme type. L'\u00E9pid\u00E9mie qui a s\u00E9vi en Afrique de l'Ouest en 2014 et 2015 a \u00E9t\u00E9 provoqu\u00E9e par un virus tr\u00E8s semblable \u00E0 celui identifi\u00E9 lors de pr\u00E9c\u00E9dentes \u00E9pid\u00E9mies en R\u00E9publique d\u00E9mocratique du Congo, en R\u00E9publique du Congo et au Gabon, une premi\u00E8re \u00E9tude ayant d'abord fait penser \u00E0 une mutation de ce virus, \u00E0 97 % identique \u00E0 celui que l'on retrouve en R\u00E9publique d\u00E9mocratique du Congo. Elle avait provoqu\u00E9 au 27 mars 2016, selon les donn\u00E9es recueillies par l'OMS \u00E0 partir des informations communiqu\u00E9es par les autorit\u00E9s des dix pays concern\u00E9s, la mort de 11 323 personnes sur 28 646 cas recens\u00E9s, soit une l\u00E9talit\u00E9 globale de 39,5 % ; si la remont\u00E9e d'informations s'est par la suite progressivement fiabilis\u00E9e, l'OMS avait cependant averti le 14 ao\u00FBt 2014 que \u00AB les \u00E9quipes op\u00E9rant sur les sites de l'\u00E9pid\u00E9mie constatent des signes \u00E9vidents que les donn\u00E9es rapport\u00E9es sur le nombre de cas et de morts sous-\u00E9valuent largement l'ampleur de l'\u00E9pid\u00E9mie \u00BB. Une nouvelle \u00E9pid\u00E9mie frappe la R\u00E9publique d\u00E9mocratique du Congo en 2019, faisant plus de 2 000 morts. En 2021, plusieurs cas sont \u00E0 nouveau d\u00E9tect\u00E9s dans la r\u00E9gion de Nz\u00E9r\u00E9kor\u00E9, au Sud-Est de la Guin\u00E9e."@fr , "A doen\u00E7a por v\u00EDrus \u00C9bola (DVE), tamb\u00E9m denominada no Brasil por doen\u00E7a por v\u00EDrus ebola, \u00E9 uma doen\u00E7a infeciosa causada pelo v\u00EDrus \u00C9bola que afeta seres humanos e outros mam\u00EDferos. Os sintomas t\u00EAm in\u00EDcio de duas a tr\u00EAs semanas ap\u00F3s contrair o v\u00EDrus, manifestando-se inicialmente por febre, garganta inflamada, dores musculares e dores de cabe\u00E7a. Estes sintomas s\u00E3o seguidos por v\u00F3mitos, diarreia e exantema, a par de insufici\u00EAncia hep\u00E1tica e renal. Nesta fase, a pessoa infetada pode apresentar hemorragias internas e externas. Em caso de morte, esta geralmente ocorre entre 6 a 16 dias ap\u00F3s o in\u00EDcio dos sintomas e na maior parte dos casos deve-se \u00E0 diminui\u00E7\u00E3o da press\u00E3o arterial resultante da perda de sangue. O v\u00EDrus pode ser adquirido atrav\u00E9s de contacto com o sangue ou outros fluidos biol\u00F3gicos de um ser humano ou animal infetado. A transmiss\u00E3o por via a\u00E9rea ainda n\u00E3o foi documentada em ambiente natural. Acredita-se que o reservat\u00F3rio natural seja o morcego-da-fruta, o qual \u00E9 capaz de propagar o v\u00EDrus sem ser afetado. Os humanos s\u00E3o infetados pelo contacto direto com os morcegos ou com animais que foram infetados pelos morcegos. Uma vez estabelecida a infe\u00E7\u00E3o humana, a doen\u00E7a pode-se tamb\u00E9m disseminar entre determinada popula\u00E7\u00E3o. Os sobreviventes do sexo masculino continuam a ser capazes de transmitir a doen\u00E7a atrav\u00E9s do s\u00E9men durante cerca de dois meses. Para o diagn\u00F3stico de DVE, s\u00E3o primeiro exclu\u00EDdas doen\u00E7as com sintomas semelhantes, como a mal\u00E1ria, c\u00F3lera ou outras febres hemorr\u00E1gicas virais. Para confirmar o diagn\u00F3stico s\u00E3o examinadas amostras de sangue para a presen\u00E7a de anticorpos virais, ARN viral ou do pr\u00F3prio v\u00EDrus. O controlo de um surto exige a coordena\u00E7\u00E3o entre v\u00E1rios servi\u00E7os m\u00E9dicos, a par de um determinado n\u00EDvel de envolvimento da comunidade. Entre os servi\u00E7os m\u00E9dicos necess\u00E1rios est\u00E3o a r\u00E1pida dete\u00E7\u00E3o e diagn\u00F3stico de pessoas de risco, r\u00E1pido acesso a servi\u00E7os de laborat\u00F3rio adequados, tratamento adequado dos infetados e gest\u00E3o adequada dos mortos atrav\u00E9s de crema\u00E7\u00E3o ou enterro. A preven\u00E7\u00E3o passa por diminuir o risco de propaga\u00E7\u00E3o da doen\u00E7a entre animais infetados e seres humanos. Isto pode ser feito atrav\u00E9s do uso de vestu\u00E1rio de prote\u00E7\u00E3o ao manusear carca\u00E7as de animais suspeitas ou garantindo que toda a carne \u00E9 plenamente cozinhada antes de ser consumida. Durante o contacto com pessoas com a doen\u00E7a, deve tamb\u00E9m ser usado vestu\u00E1rio de prote\u00E7\u00E3o adequado e as m\u00E3os devem ser frequentemente lavadas. As amostras de tecidos e fluidos corporais de pessoas infetadas devem ser manuseadas com especial precau\u00E7\u00E3o. N\u00E3o est\u00E1 ainda dispon\u00EDvel qualquer tratamento espec\u00EDfico para a doen\u00E7a. Os cuidados de apoio envolvem a terapia de reidrata\u00E7\u00E3o oral (administra\u00E7\u00E3o de \u00E1gua ligeiramente doce e salgada) ou terapia intravenosa, sendo capazes de melhorar o progn\u00F3stico da doen\u00E7a. A doen\u00E7a apresenta elevado risco de morte, matando entre 25% e 90% das pessoas infetadas, com m\u00E9dia de 50%. A DVE foi identificada pela primeira vez numa regi\u00E3o do Sud\u00E3o e no Zaire, atual Rep\u00FAblica Democr\u00E1tica do Congo. A doen\u00E7a geralmente ocorre em surtos em regi\u00F5es tropicais da \u00C1frica subsariana. Entre 1976, ano em que foi pela primeira vez identificada, e 2013, a Organiza\u00E7\u00E3o Mundial de Sa\u00FAde reportou um total de 1716 casos. O maior surto verificado at\u00E9 hoje foi o surto de \u00E9bola na \u00C1frica Ocidental de 2014, que atualmente afeta a Guin\u00E9-Conacri, a Serra Leoa e a Lib\u00E9ria. Est\u00E3o em curso medidas para desenvolver uma vacina, embora ainda n\u00E3o exista nenhuma. Em 2017, cientistas da Universidade de Queensland, na Austr\u00E1lia, desenvolveram um tratamento eficaz, r\u00E1pido e econ\u00F3mico para o v\u00EDrus \u00C9bola usando anticorpos de cavalos."@pt ; dbp:complications dbr:Hypovolemic_shock ; dbp:dSearch "Q51993"@en ; dbp:differential "Malaria, cholera, typhoid fever, meningitis, other viral haemorrhagic fevers"@en ; dbp:emedicinesubj "med"@en ; dbp:emedicinetopic 626 ; dbp:medication ns10:odesivimab ; dbp:prevention "Coordinated medical services, careful handling of bushmeat"@en ; dbp:prognosis 25 ; dbo:icd9 "078.89" ; dbo:eMedicineSubject "med"@en ; dbo:eMedicineTopic "626"@en ; dbo:meshId "D019142" . @prefix prov: . dbr:Ebola prov:wasDerivedFrom ; dbo:wikiPageLength "188797"^^xsd:nonNegativeInteger ; dbo:alias "Ebola haemorrhagic fever (EHF), Ebola virus disease"@en ; dbo:diseasesDB "18043" ; dbo:icd10 "A98.4" ; dbo:medlinePlus "001339" . @prefix wikipedia-en: . dbr:Ebola foaf:isPrimaryTopicOf wikipedia-en:Ebola .